AML1	B-protein
(	I-protein
CBFalpha2	I-protein
)	I-protein
cooperates	O
with	O
B	B-protein
cell-specific	I-protein
activating	I-protein
protein	I-protein
(	I-protein
BSAP/PAX5	I-protein
)	I-protein
in	O
activation	O
of	O
the	O
B	B-DNA
cell-specific	I-DNA
BLK	I-DNA
gene	I-DNA
promoter	I-DNA
.	O

AML1	B-protein
plays	O
a	O
critical	O
role	O
during	O
hematopoiesis	O
and	O
chromosomal	O
translocations	O
involving	O
AML1	B-protein
are	O
commonly	O
associated	O
with	O
different	O
forms	O
of	O
leukemia	O
,	O
including	O
pre-B	O
acute	O
lymphoblastic	O
leukemia	O
.	O

To	O
understand	O
the	O
function	O
of	O
AML1	B-protein
during	O
B	B-cell_type
cell	I-cell_type
differentiation	O
,	O
we	O
analyzed	O
regulatory	B-DNA
regions	I-DNA
of	O
B	B-DNA
cell-specific	I-DNA
genes	I-DNA
for	O
potential	O
AML1-binding	B-DNA
sites	I-DNA
and	O
have	O
identified	O
a	O
putative	O
AML1-binding	B-DNA
site	I-DNA
in	O
the	O
promoter	O
of	O
the	O
B	B-DNA
cell-specific	I-DNA
tyrosine	I-DNA
kinase	I-DNA
gene	I-DNA
,	I-DNA
blk	I-DNA
.	O

Gel	O
mobility	O
shift	O
assays	O
and	O
transient	O
transfection	O
assays	O
demonstrate	O
that	O
AML1	B-protein
binds	O
specifically	O
to	O
this	O
site	O
in	O
the	O
blk	B-DNA
promoter	I-DNA
and	O
this	O
binding	O
site	O
is	O
important	O
for	O
blk	B-DNA
promoter	O
activity	O
.	O

Furthermore	O
,	O
in	O
vitro	O
binding	O
analysis	O
revealed	O
that	O
the	O
AML1	B-DNA
runt	I-DNA
DNA-binding	I-DNA
domain	I-DNA
physically	O
interacts	O
with	O
the	O
paired	B-DNA
DNA-binding	I-DNA
domain	I-DNA
of	O
BSAP	B-protein
,	O
a	O
B	B-protein
cell-specific	I-protein
transcription	I-protein
factor	I-protein
.	O

BSAP	B-protein
has	O
been	O
shown	O
previously	O
to	O
be	O
important	O
for	O
B	O
cell-specific	O
regulation	O
of	O
the	O
blk	B-DNA
gene	O
.	O

Physical	O
interaction	O
of	O
AML1	B-protein
with	O
BSAP	B-protein
correlates	O
with	O
functional	O
cooperativity	O
in	O
transfection	O
studies	O
where	O
AML1	B-protein
and	O
BSAP	B-protein
synergistically	O
activate	O
blk	B-DNA
promoter	O
transcription	O
by	O
more	O
than	O
50-fold	O
.	O

These	O
results	O
demonstrate	O
physical	O
and	O
functional	O
interactions	O
between	O
AML1	B-protein
and	O
BSAP	B-protein
and	O
suggest	O
that	O
AML1	B-protein
is	O
an	O
important	O
factor	O
for	O
regulating	O
a	O
critical	O
B	B-DNA
cell-specific	I-DNA
gene	I-DNA
,	O
blk	B-DNA
.	O

THE	NULL
JOURNAL	NULL
oF	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

274	NULL
,	NULL
No	NULL
.	NULL

35	NULL
,	NULL
Issue	NULL
of	NULL
August	NULL
27	NULL
,	NULL
pp	NULL
.	NULL

24671-24676	NULL
,	NULL
1999	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
AML1	NULL
(	NULL
CBFa2	NULL
)	NULL
Cooperates	NULL
with	NULL
B	NULL
Cell-specific	NULL
Activating	NULL
Protein	NULL
(	NULL
BSAP/PAX5	NULL
)	NULL
in	NULL
Activation	NULL
of	NULL
the	NULL
B	NULL
Cell-specific	NULL
BLK	NULL
Gene	NULL
Promoter*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
April	NULL
13	NULL
,	NULL
1999	NULL
)	NULL
Towia	NULL
A.	NULL
Libermannt§	NULL
,	NULL
Zheng	NULL
Pan§	NULL
,	NULL
Yasmin	NULL
Akbaralif§	NULL
,	NULL
Christopher	NULL
J.	NULL
Hetherington	NULL
,	NULL
Jay	NULL
Boltax	NULL
$	NULL
§	NULL
,	NULL
Donald	NULL
A.	NULL
Yergeau	NULL
$	NULL
§	NULL
,	NULL
and	NULL
Dong-Er	NULL
Zhang§1	NULL
From	NULL
the	NULL
{	NULL
New	NULL
England	NULL
Baptist	NULL
Bone	NULL
and	NULL
Joint	NULL
Institute	NULL
,	NULL
and	NULL
§Department	NULL
of	NULL
Medicine	NULL
,	NULL
Beth	NULL
Israel	NULL
Deaconess	NULL
Medical	NULL
Center	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02115	NULL
AML1	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
during	NULL
hematopoiesis	NULL
and	NULL
chromosomal	NULL
translocations	NULL
involving	NULL
AML1	NULL
are	NULL
commonly	NULL
associated	NULL
with	NULL
different	NULL
forms	NULL
of	NULL
leukemia	NULL
,	NULL
including	NULL
pre-B	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
.	NULL

To	NULL
understand	NULL
the	NULL
function	NULL
of	NULL
AML1	NULL
during	NULL
B	NULL
cell	NULL
differentiation	NULL
,	NULL
we	NULL
analyzed	NULL
regulatory	NULL
regions	NULL
of	NULL
B	NULL
cell-specific	NULL
genes	NULL
for	NULL
potential	NULL
AML1-binding	NULL
sites	NULL
and	NULL
have	NULL
identified	NULL
a	NULL
putative	NULL
AML1-binding	NULL
site	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
B	NULL
cell-specific	NULL
tyrosine	NULL
kinase	NULL
gene	NULL
,	NULL
bik	NULL
.	NULL

Gel	NULL
mobility	NULL
shift	NULL
assays	NULL
and	NULL
transient	NULL
transfection	NULL
assays	NULL
demonstrate	NULL
that	NULL
AML1	NULL
binds	NULL
specifically	NULL
to	NULL
this	NULL
site	NULL
in	NULL
the	NULL
blk	NULL
promoter	NULL
and	NULL
this	NULL
binding	NULL
site	NULL
is	NULL
important	NULL
for	NULL
blk	NULL
promoter	NULL
activity	NULL
.	NULL

Furthermore	NULL
,	NULL
in	NULL
vitro	NULL
binding	NULL
analysis	NULL
revealed	NULL
that	NULL
the	NULL
AML1	NULL
runt	NULL
DNA-binding	NULL
domain	NULL
physically	NULL
interacts	NULL
with	NULL
the	NULL
paired	NULL
DNA-binding	NULL
domain	NULL
of	NULL
BSAP	NULL
,	NULL
a	NULL
B	NULL
cell-specific	NULL
transcription	NULL
factor	NULL
.	NULL

BSAP	NULL
has	NULL
been	NULL
shown	NULL
previously	NULL
to	NULL
be	NULL
important	NULL
for	NULL
B	NULL
cell-specific	NULL
regulation	NULL
of	NULL
the	NULL
bik	NULL
gene	NULL
.	NULL

Physical	NULL
interaction	NULL
of	NULL
AML1	NULL
with	NULL
BSAP	NULL
correlates	NULL
with	NULL
functional	NULL
cooperativity	NULL
in	NULL
transfection	NULL
studies	NULL
where	NULL
AML1	NULL
and	NULL
BSAP	NULL
synergistically	NULL
activate	NULL
blk	NULL
promoter	NULL
transcription	NULL
by	NULL
more	NULL
than	NULL
50-fold	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
physical	NULL
and	NULL
functional	NULL
interactions	NULL
between	NULL
AML1	NULL
and	NULL
BSAP	NULL
and	NULL
suggest	NULL
that	NULL
AML1	NULL
is	NULL
an	NULL
important	NULL
factor	NULL
for	NULL
regulating	NULL
a	NULL
critical	NULL
B	NULL
cell-specific	NULL
gene	NULL
,	NULL
blk	NULL
.	NULL

AML1	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
PEBP2/CBEF	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

These	NULL
factors	NULL
consist	NULL
of	NULL
heterodimers	NULL
between	NULL
the	NULL
DNA	NULL
binding	NULL
a	NULL
subunit	NULL
and	NULL
the	NULL
subunit	NULL
,	NULL
CBFB	NULL
,	NULL
which	NULL
does	NULL
not	NULL
bind	NULL
DNA	NULL
directly	NULL
but	NULL
enhances	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
a	NULL
subunit	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Multiple	NULL
a	NULL
subunit	NULL
genes	NULL
,	NULL
including	NULL
CBFal	NULL
(	NULL
AML3	NULL
)	NULL
,	NULL
AML1	NULL
(	NULL
CBFa2	NULL
)	NULL
,	NULL
and	NULL
CBFa3	NULL
(	NULL
AML2	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
alternatively	NULL
spliced	NULL
isoforms	NULL
of	NULL
the	NULL
«	NULL
and	NULL
B	NULL
subunits	NULL
have	NULL
been	NULL
detected	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

All	NULL
of	NULL
the	NULL
CBFa	NULL
proteins	NULL
have	NULL
a	NULL
DNA-binding	NULL
domain	NULL
(	NULL
the	NULL
runt	NULL
domain	NULL
)	NULL
,	NULL
which	NULL
is	NULL
similar	NULL
to	NULL
the	NULL
Drosophila	NULL
pair-rule	NULL
gene	NULL
,	NULL
runt	NULL
(	NULL
6	NULL
)	NULL
.	NULL

AML1	NULL
and	NULL
other	NULL
PEBP2/CBFa	NULL
«	NULL
proteins	NULL
are	NULL
transcription	NULL
factors	NULL
whose	NULL
recognition	NULL
sequence	NULL
is	NULL
required	NULL
for	NULL
tissue	NULL
specific	NULL
expression	NULL
of	NULL
several	NULL
hematopoietic	NULL
genes	NULL
including	NULL
M-CSF	NULL
receptor	NULL
,	NULL
GM-CSF	NULL
,	NULL
IL-3	NULL
,	NULL
T	NULL
cell	NULL
receptors	NULL
,	NULL
immunoglob-	NULL
ulin	NULL
u	NULL
heavy	NULL
chain	NULL
,	NULL
defensin	NULL
NP-3	NULL
,	NULL
and	NULL
myeloperoxidase	NULL
(	NULL
7-	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
AI39613	NULL
(	NULL
to	NULL
T.	NULL
A.	NULL
L.	NULL
)	NULL
,	NULL
CA/AI59589	NULL
(	NULL
to	NULL
D.	NULL
E	NULL
.	NULL

Z	NULL
.	NULL
)	NULL

,	NULL
and	NULL
CA72009	NULL
(	NULL
to	NULL
D.	NULL
E.	NULL
Z.	NULL
and	NULL
T.	NULL
A.	NULL
L.	NULL
)	NULL
and	NULL
American	NULL
Cancer	NULL
Society	NULL
Grant	NULL
DHP-166	NULL
(	NULL
to	NULL
D.	NULL
E	NULL
.	NULL

Z	NULL
.	NULL
)	NULL

.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1784	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

«	NULL
]	NULL
Leukemia	NULL
Society	NULL
of	NULL
America	NULL
Scholar	NULL
.	NULL

To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Rm	NULL
.	NULL

953	NULL
,	NULL
Harvard	NULL
Institutes	NULL
of	NULL
Medicine	NULL
,	NULL
77	NULL
Ave.	NULL
Louis	NULL
Pasteur	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02115	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
617-667-8930	NULL
;	NULL
Fax	NULL
:	NULL
617-667-3299	NULL
;	NULL
E-mail	NULL
:	NULL
dzhang	NULL
@	NULL
bidmc.harvard.edu	NULL
.	NULL

This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www.jbc.org	NULL
15	NULL
)	NULL
.	NULL

AML1	NULL
knockout	NULL
mice	NULL
indicate	NULL
,	NULL
furthermore	NULL
,	NULL
that	NULL
AML1	NULL
is	NULL
indeed	NULL
a	NULL
critical	NULL
regulator	NULL
of	NULL
early	NULL
hematopoiesis	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

The	NULL
AML1	NULL
gene	NULL
is	NULL
frequently	NULL
associated	NULL
with	NULL
chromosomal	NULL
translocations	NULL
in	NULL
different	NULL
forms	NULL
of	NULL
leukemia	NULL
,	NULL
including	NULL
t	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
,	NULL
t	NULL
(	NULL
3	NULL
;	NULL
21	NULL
)	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
t	NULL
(	NULL
12	NULL
;	NULL
21	NULL
)	NULL
(	NULL
1	NULL
,	NULL
18-20	NULL
)	NULL
.	NULL

The	NULL
B	NULL
subunit	NULL
of	NULL
PEBP2/	NULL
CBF	NULL
is	NULL
also	NULL
involved	NULL
in	NULL
a	NULL
chromosomal	NULL
inversion	NULL
,	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
,	NULL
associated	NULL
with	NULL
FAB	NULL
M4eo	NULL
AML	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
each	NULL
of	NULL
the	NULL
two	NULL
chains	NULL
of	NULL
the	NULL
PEBP2/CBF	NULL
heterodimer	NULL
is	NULL
directly	NULL
implicated	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
leukemia	NULL
.	NULL

T	NULL
(	NULL
12	NULL
;	NULL
21	NULL
)	NULL
is	NULL
a	NULL
common	NULL
chromosomal	NULL
abnormality	NULL
in	NULL
childhood	NULL
pre-B	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
(	NULL
20	NULL
,	NULL
22	NULL
)	NULL
.	NULL

This	NULL
translocation	NULL
generates	NULL
two	NULL
chimeric	NULL
genes	NULL
,	NULL
TEL	NULL
/AML1	NULL
and	NULL
AML1/	NULL
TEL	NULL
.	NULL

Only	NULL
the	NULL
TEL	NULL
/AML1	NULL
chimeric	NULL
gene	NULL
product	NULL
is	NULL
consistently	NULL
detected	NULL
in	NULL
cells	NULL
with	NULL
t	NULL
(	NULL
12	NULL
;	NULL
21	NULL
)	NULL
(	NULL
23	NULL
)	NULL
.	NULL

The	NULL
TEL/AML1	NULL
chimeric	NULL
gene	NULL
expresses	NULL
a	NULL
fusion	NULL
protein	NULL
that	NULL
contains	NULL
the	NULL
333	NULL
NH	NULL
,	NULL
-terminal	NULL
amino	NULL
acids	NULL
of	NULL
the	NULL
TEL	NULL
protein	NULL
encoding	NULL
the	NULL
Pointed	NULL
dimerization	NULL
domain	NULL
but	NULL
lacking	NULL
the	NULL
Ets	NULL
DNA-binding	NULL
domain	NULL
,	NULL
and	NULL
almost	NULL
the	NULL
entire	NULL
AML1	NULL
protein	NULL
,	NULL
including	NULL
the	NULL
AML1	NULL
DNA-binding	NULL
domain	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
TEL/AML1	NULL
fusion	NULL
protein	NULL
can	NULL
interact	NULL
with	NULL
AML1	NULL
DNA-binding	NULL
sites	NULL
and	NULL
possibly	NULL
interfere	NULL
with	NULL
AMLL	NULL
function	NULL
during	NULL
B	NULL
cell	NULL
differentiation	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
AML1	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
controlling	NULL
gene	NULL
expression	NULL
during	NULL
normal	NULL
B	NULL
cell	NULL
differentiation	NULL
.	NULL

To	NULL
study	NULL
the	NULL
function	NULL
of	NULL
AML1	NULL
in	NULL
B-cell	NULL
differentiation	NULL
,	NULL
we	NULL
analyzed	NULL
regulatory	NULL
regions	NULL
of	NULL
B	NULL
cell-specific	NULL
genes	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
AML1l-binding	NULL
sites	NULL
.	NULL

We	NULL
observed	NULL
a	NULL
consensus	NULL
AML1-binding	NULL
site	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
bik	NULL
gene	NULL
.	NULL

BLK	NULL
,	NULL
a	NULL
Src	NULL
family	NULL
member	NULL
,	NULL
encodes	NULL
a	NULL
B	NULL
cell-specific	NULL
,	NULL
55-kDa	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
p55	NULL
``	NULL
(	NULL
24	NULL
)	NULL
.	NULL

BLK	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
B	NULL
cell	NULL
antigen	NULL
receptor	NULL
and	NULL
is	NULL
involved	NULL
in	NULL
signal	NULL
transduction	NULL
events	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
B	NULL
cell	NULL
antigen	NULL
receptor	NULL
complex	NULL
is	NULL
formed	NULL
by	NULL
membrane	NULL
IgM	NULL
noncovalently	NULL
associated	NULL
with	NULL
heterodimers	NULL
of	NULL
B29	NULL
and	NULL
mb-1	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
.	NULL

Antigen	NULL
cross-linking	NULL
to	NULL
the	NULL
B	NULL
cell	NULL
antigen	NULL
receptor	NULL
leads	NULL
to	NULL
a	NULL
rapid	NULL
and	NULL
transient	NULL
increase	NULL
in	NULL
tyrosine	NULL
kinase	NULL
activity	NULL
resulting	NULL
in	NULL
activation	NULL
of	NULL
several	NULL
signal	NULL
transduction	NULL
pathways	NULL
,	NULL
including	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
pathway	NULL
.	NULL

The	NULL
antigen	NULL
receptor	NULL
does	NULL
not	NULL
itself	NULL
contain	NULL
an	NULL
intrinsic	NULL
tyrosine	NULL
kinase	NULL
domain	NULL
;	NULL
therefore	NULL
,	NULL
tyrosine	NULL
kinase	NULL
activation	NULL
is	NULL
due	NULL
to	NULL
signal	NULL
transduction	NULL
mediated	NULL
through	NULL
interaction	NULL
of	NULL
two	NULL
B	NULL
cell	NULL
antigen	NULL
receptor-associated	NULL
proteins	NULL
,	NULL
Iga	NULL
(	NULL
mb-1	NULL
)	NULL
and	NULL
IgB	NULL
(	NULL
B29	NULL
)	NULL
with	NULL
the	NULL
cytoplasmic	NULL
Sre-like	NULL
kinases	NULL
,	NULL
BLK	NULL
,	NULL
LYN	NULL
,	NULL
and	NULL
FYN	NULL
(	NULL
28	NULL
)	NULL
.	NULL

This	NULL
rapid	NULL
and	NULL
transient	NULL
activation	NULL
of	NULL
tyrosine	NULL
kinases	NULL
triggers	NULL
a	NULL
cascade	NULL
of	NULL
downstream	NULL
events	NULL
,	NULL
leading	NULL
to	NULL
changes	NULL
in	NULL
gene	NULL
expression	NULL
and	NULL
either	NULL
cell	NULL
proliferation	NULL
and	NULL
differentiation	NULL
or	NULL
apoptosis	NULL
.	NULL

BLK	NULL
is	NULL
exclusively	NULL
expressed	NULL
in	NULL
B	NULL
cells	NULL
at	NULL
the	NULL
pro-B	NULL
,	NULL
pre-B	NULL
,	NULL
and	NULL
mature	NULL
B	NULL
cell	NULL
stages	NULL
,	NULL
but	NULL
not	NULL
in	NULL
plasma	NULL
cells	NULL
or	NULL
non-B	NULL
cells	NULL
(	NULL
29	NULL
)	NULL
.	NULL

The	NULL
function	NULL
of	NULL
BLK	NULL
in	NULL
B	NULL
cell	NULL
antigen	NULL
receptor	NULL
signaling	NULL
is	NULL
not	NULL
clear	NULL
,	NULL
although	NULL
several	NULL
studies	NULL
have	NULL
implicated	NULL
the	NULL
BLK	NULL
kinase	NULL
in	NULL
antigen	NULL
receptor	NULL
cross-linking	NULL
mediated	NULL
growth	NULL
arrest	NULL
and	NULL
apoptosis	NULL
(	NULL
30	NULL
,	NULL
31	NULL
)	NULL
.	NULL

24671	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
24672	NULL
However	NULL
,	NULL
transgenic	NULL
mice	NULL
expressing	NULL
a	NULL
constitutively	NULL
activated	NULL
BLK	NULL
mutant	NULL
in	NULL
the	NULL
B	NULL
cell	NULL
lineage	NULL
develop	NULL
B	NULL
lymphoid	NULL
tumors	NULL
(	NULL
82	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
control	NULL
of	NULL
blk	NULL
gene	NULL
expression	NULL
could	NULL
be	NULL
directly	NULL
related	NULL
to	NULL
B	NULL
cell	NULL
development	NULL
and	NULL
neoplasia	NULL
.	NULL

B	NULL
cell	NULL
specificity	NULL
of	NULL
bik	NULL
gene	NULL
expression	NULL
is	NULL
primarily	NULL
regulated	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
and	NULL
a	NULL
320-bp	NULL
'	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
murine	NULL
bik	NULL
promoter	NULL
appears	NULL
to	NULL
contain	NULL
most	NULL
of	NULL
the	NULL
B	NULL
cell-specific	NULL
regulatory	NULL
elements	NULL
(	NULL
29	NULL
,	NULL
33	NULL
)	NULL
.	NULL

Relatively	NULL
little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
bik	NULL
gene	NULL
expression	NULL
.	NULL

It	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
B	NULL
cell-specific	NULL
activator	NULL
protein	NULL
(	NULL
BSAP/Pax5	NULL
)	NULL
binds	NULL
to	NULL
the	NULL
bik	NULL
promoter	NULL
,	NULL
and	NULL
recently	NULL
BSAP	NULL
as	NULL
well	NULL
as	NULL
NF-	NULL
«	NULL
B	NULL
were	NULL
shown	NULL
to	NULL
transactivate	NULL
the	NULL
bik	NULL
promoter	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

BSAP	NULL
is	NULL
a	NULL
critical	NULL
transcription	NULL
factor	NULL
for	NULL
B	NULL
cell	NULL
development	NULL
with	NULL
a	NULL
similar	NULL
expression	NULL
pattern	NULL
as	NULL
BLK	NULL
(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
.	NULL

BSAP	NULL
belongs	NULL
to	NULL
the	NULL
paired	NULL
box	NULL
(	NULL
Pax	NULL
)	NULL
gene	NULL
family	NULL
,	NULL
which	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
during	NULL
the	NULL
development	NULL
of	NULL
the	NULL
central	NULL
nervous	NULL
system	NULL
and	NULL
during	NULL
B	NULL
cell	NULL
development	NULL
(	NULL
35-37	NULL
)	NULL
.	NULL

BSAP	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
act	NULL
as	NULL
both	NULL
a	NULL
positive	NULL
and	NULL
negative	NULL
regulator	NULL
of	NULL
gene	NULL
expression	NULL
controlling	NULL
the	NULL
expression	NULL
of	NULL
several	NULL
B	NULL
cell-specific	NULL
genes	NULL
including	NULL
CD19	NULL
,	NULL
bik	NULL
,	NULL
and	NULL
various	NULL
immunoglobulin	NULL
genes	NULL
(	NULL
83	NULL
,	NULL
38-43	NULL
)	NULL
.	NULL

We	NULL
now	NULL
report	NULL
that	NULL
AML1	NULL
binds	NULL
to	NULL
a	NULL
functionally	NULL
important	NULL
region	NULL
of	NULL
the	NULL
bik	NULL
promoter	NULL
,	NULL
directly	NULL
interacts	NULL
with	NULL
the	NULL
paired	NULL
box	NULL
DNA-binding	NULL
domain	NULL
of	NULL
BSAP	NULL
protein	NULL
through	NULL
its	NULL
runt	NULL
homology	NULL
domain	NULL
,	NULL
and	NULL
cooperates	NULL
with	NULL
BSAP	NULL
in	NULL
activating	NULL
bik	NULL
promoter	NULL
transcription	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
(	NULL
EMSA	NULL
)	NULL
-The	NULL
probe	NULL
for	NULL
the	NULL
EMSA	NULL
was	NULL
a	NULL
double-stranded	NULL
oligonucleotide	NULL
with	NULL
bp	NULL
-47	NULL
to	NULL
-28	NULL
of	NULL
the	NULL
blk	NULL
upstream	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

A	NULL
*°P-labeled	NULL
probe	NULL
was	NULL
prepared	NULL
by	NULL
T4	NULL
kinase	NULL
phosphorylation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
y-*°PJATP	NULL
(	NULL
NEN	NULL
Life	NULL
Science	NULL
Products	NULL
Inc.	NULL
)	NULL
.	NULL

Nuclear	NULL
protein	NULL
for	NULL
the	NULL
EMSA	NULL
was	NULL
prepared	NULL
from	NULL
Ba/F3	NULL
cells	NULL
according	NULL
to	NULL
the	NULL
method	NULL
published	NULL
by	NULL
Schreiber	NULL
et	NULL
al	NULL
.	NULL

(	NULL
44	NULL
)	NULL
.	NULL

Approximately	NULL
0.5	NULL
ng	NULL
of	NULL
probe	NULL
was	NULL
incubated	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
nuclear	NULL
protein	NULL
or	NULL
1	NULL
pl	NULL
of	NULL
in	NULL
vitro	NULL
translated	NULL
protein	NULL
in	NULL
20	NULL
ul	NULL
of	NULL
binding	NULL
buffer	NULL
containing	NULL
10	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
30	NULL
mm	NULL
KCl	NULL
,	NULL
5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.4	NULL
mM	NULL
phenylmethylsulfony	NULL
]	NULL
fluoride	NULL
,	NULL
12	NULL
%	NULL
glycerol	NULL
at	NULL
4	NULL
°C	NULL
for	NULL
20	NULL
min	NULL
(	NULL
45	NULL
)	NULL
.	NULL

All	NULL
reactions	NULL
contain	NULL
1	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
.	NULL

Reactions	NULL
were	NULL
electrophoresed	NULL
at	NULL
10	NULL
V/cm	NULL
on	NULL
a	NULL
6	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
(	NULL
bisacrylamide/acrylamide	NULL
ratio	NULL
=	NULL
1:29	NULL
)	NULL
in	NULL
0.5	NULL
X	NULL
TBE	NULL
(	NULL
45	NULL
mM	NULL
Tris	NULL
borate	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
)	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

For	NULL
supershift	NULL
experiments	NULL
,	NULL
1	NULL
ul	NULL
of	NULL
poly-clonal	NULL
rabbit	NULL
antiserum	NULL
raised	NULL
against	NULL
a	NULL
17-amino	NULL
acid	NULL
NH	NULL
,	NULL
-terminal	NULL
peptide	NULL
from	NULL
AML1	NULL
was	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
mixture	NULL
10	NULL
min	NULL
prior	NULL
to	NULL
addition	NULL
of	NULL
the	NULL
probe	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Plasmid	NULL
Construction-A	NULL
murine	NULL
blk	NULL
promoter	NULL
(	NULL
bp	NULL
-191	NULL
to	NULL
+136	NULL
)	NULL
DNA	NULL
fragment	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
KpnI	NULL
and	NULL
Xhol	NULL
sites	NULL
of	NULL
the	NULL
pXP2	NULL
luciferase	NULL
reporter	NULL
gene	NULL
construct	NULL
to	NULL
form	NULL
pBlk-lue	NULL
(	NULL
47	NULL
)	NULL
.	NULL

pBlk-lue-	NULL
(	NULL
mAML1	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
a	NULL
mutation	NULL
at	NULL
the	NULL
AML1	NULL
binding	NULL
was	NULL
generated	NULL
using	NULL
QuickChange	NULL
Mutagenesis	NULL
Kit	NULL
(	NULL
Stratagene	NULL
)	NULL
.	NULL

The	NULL
AML1	NULL
site	NULL
was	NULL
changed	NULL
from	NULL
TGTGGT	NULL
to	NULL
TGCACT	NULL
.	NULL

AML1	NULL
and	NULL
CBFR	NULL
expression	NULL
constructs	NULL
,	NULL
pCMV5-AML1	NULL
and	NULL
pCMV5-CBFB	NULL
,	NULL
were	NULL
received	NULL
from	NULL
Dr.	NULL
Scott	NULL
Hiebert	NULL
(	NULL
46	NULL
)	NULL
.	NULL

BSAP	NULL
cDNA	NULL
was	NULL
received	NULL
from	NULL
Dr.	NULL
Steve	NULL
Desiderio	NULL
(	NULL
83	NULL
)	NULL
and	NULL
inserted	NULL
into	NULL
the	NULL
NofI	NULL
site	NULL
of	NULL
the	NULL
pCI	NULL
expression	NULL
vector	NULL
.	NULL

The	NULL
GST-BSAP	NULL
full-length	NULL
fusion	NULL
protein	NULL
was	NULL
generated	NULL
by	NULL
inserting	NULL
a	NULL
blunt-ended	NULL
NotI	NULL
fragment	NULL
of	NULL
the	NULL
BSAP	NULL
cDNA	NULL
into	NULL
the	NULL
Smal	NULL
site	NULL
of	NULL
pGEX-5X-3	NULL
.	NULL

GST-BSAP	NULL
;	NULL
;	NULL
,	NULL
,	NULL
and	NULL
GST-BSAP	NULL
;	NULL
;	NULL
,	NULL
,	NULL
were	NULL
generated	NULL
by	NULL
deleting	NULL
a	NULL
Smal-Xhol	NULL
fragment	NULL
or	NULL
a	NULL
Sacll-Xhol	NULL
fragment	NULL
from	NULL
the	NULL
carboxyl	NULL
terminus	NULL
of	NULL
GST-BSAP	NULL
,	NULL
respectively	NULL
.	NULL

GST-BSAP	NULL
pq	NULL
,	NULL
39	NULL
,	NULL
was	NULL
generated	NULL
by	NULL
inserting	NULL
a	NULL
Puull-NofI	NULL
fragment	NULL
of	NULL
BSAP	NULL
into	NULL
BamHI	NULL
(	NULL
blunt	NULL
ended	NULL
)	NULL
and	NULL
NotI	NULL
sites	NULL
of	NULL
pGES-5X-8	NULL
.	NULL

Full-length	NULL
AML1	NULL
,	NULL
AML1	NULL
,	NULL
_	NULL
20s	NULL
,	NULL
and	NULL
AML1	NULL
,	NULL
;	NULL
_	NULL
,	NULL
,	NULL
;	NULL
were	NULL
as	NULL
reported	NULL
previously	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Cell	NULL
Culture	NULL
and	NULL
Transfection-The	NULL
human	NULL
B	NULL
cell	NULL
line	NULL
BJA-B	NULL
,	NULL
promonocytic	NULL
cell	NULL
line	NULL
THP-1	NULL
,	NULL
and	NULL
murine	NULL
B	NULL
cell	NULL
line	NULL
Ba/F3	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
and	NULL
2	NULL
mM	NULL
L-glutamine	NULL
.	NULL

THP-1	NULL
cell	NULL
culture	NULL
medium	NULL
contained	NULL
2	NULL
X	NULL
10°	NULL
M	NULL
2-mercaptoethanol	NULL
.	NULL

Ba/F3	NULL
cell	NULL
culture	NULL
medium	NULL
also	NULL
contained	NULL
10	NULL
%	NULL
conditioned	NULL
WEHI-3B	NULL
medium	NULL
as	NULL
a	NULL
source	NULL
for	NULL
interleukin-3	NULL
.	NULL

Maintenance	NULL
and	NULL
transfection	NULL
of	NULL
CV-1	NULL
cells	NULL
were	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
48	NULL
)	NULL
.	NULL

BJA-B	NULL
and	NULL
Ba/F3	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
in	NULL
RPMI	NULL
'	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
;	NULL
BSAP	NULL
,	NULL
B	NULL
cell-specific	NULL
activating	NULL
protein	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
GST	NULL
,	NULL
glutathione	NULL
S-transferase	NULL
;	NULL
a.a.	NULL
,	NULL
amino	NULL
acid	NULL
(	NULL
s	NULL
)	NULL
.	NULL

AML	NULL
1	NULL
Regulates	NULL
the	NULL
blk	NULL
Promoter	NULL
-186	NULL
TTTAAAAGCA	NULL
AAGCAAACGCC	NULL
AATGCGACTGA	NULL
GAGAACCCCG	NULL
-146	NULL
CCCTAGTTCC	NULL
CACARGGTGGC	NULL
CCACGACGGAA	NULL
CCCTCTGAAA	NULL
HLH	NULL
-106	NULL
AATACTTCCT	NULL
GGAGATAGTT	NULL
GGAGGTGTGT	NULL
TGACCCTAAC	NULL
TS	NULL
-§6	NULL
AAACCAACCA	NULL
AGGGGAAACA	NULL
CCAGCCGTGT	NULL
GGTGAACCAA	NULL
BSAP	NULL
AML1	NULL
-26	NULL
AACCCATGAG	NULL
AAAACTTTGG	NULL
GGTGGCAGAG	NULL
GGGCATCATG	NULL
G	NULL
CTGAAGGTCA	NULL
GCTGCCCATG	NULL
AAACTTCCTC	NULL
AP-1	NULL
ETS	NULL
BSAP	NULL
7	NULL
HLH	NULL
AML1L	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

5'-Flanking	NULL
sequence	NULL
of	NULL
the	NULL
murine	NULL
blk	NULL
gene	NULL
.	NULL

This	NULL
DNA	NULL
sequence	NULL
is	NULL
under	NULL
GenBank	NULL
accession	NULL
number	NULL
M81822	NULL
.	NULL

The	NULL
major	NULL
transcription	NULL
initiation	NULL
site	NULL
is	NULL
numbered	NULL
as	NULL
+1	NULL
and	NULL
marked	NULL
with	NULL
an	NULL
arrow	NULL
.	NULL

Potential	NULL
transcription	NULL
factor	NULL
binding	NULL
sequences	NULL
are	NULL
underlined	NULL
.	NULL

1640	NULL
medium	NULL
at	NULL
960	NULL
microfarads	NULL
and	NULL
220	NULL
or	NULL
270	NULL
V	NULL
,	NULL
respectively	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
5	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

Rous	NULL
sarcoma	NULL
virus-human	NULL
growth	NULL
hormone	NULL
expression	NULL
construct	NULL
was	NULL
co-transfected	NULL
with	NULL
luciferase	NULL
reporter	NULL
constructs	NULL
for	NULL
normalizing	NULL
transfection	NULL
efficiency	NULL
(	NULL
45	NULL
)	NULL
.	NULL

In	NULL
Vitro	NULL
Translation-Protein	NULL
in	NULL
vitro	NULL
translation	NULL
was	NULL
performed	NULL
with	NULL
TnT	NULL
T7-coupled	NULL
reticulocyte	NULL
lysate	NULL
system	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
protocol	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

The	NULL
TnT	NULL
lysate	NULL
contains	NULL
approximately	NULL
150	NULL
ug/ul	NULL
endogenous	NULL
protein	NULL
.	NULL

Each	NULL
in	NULL
vitro	NULL
translation	NULL
reaction	NULL
uses	NULL
25	NULL
ul	NULL
of	NULL
TnT	NULL
lysate	NULL
in	NULL
a	NULL
50	NULL
ul	NULL
of	NULL
reaction	NULL
.	NULL

GST	NULL
Pull-down	NULL
Experiments-The	NULL
GST	NULL
-pull	NULL
down	NULL
experiments	NULL
were	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
49	NULL
)	NULL
.	NULL

RESULTS	NULL
AML1	NULL
Interacts	NULL
with	NULL
a	NULL
Sequence	NULL
3	NULL
'	NULL
of	NULL
the	NULL
BSAP	NULL
Site	NULL
of	NULL
the	NULL
Murine	NULL
blk	NULL
Promoter-The	NULL
TEL/AML1L	NULL
fusion	NULL
protein	NULL
is	NULL
associated	NULL
with	NULL
pre-B	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
.	NULL

Since	NULL
the	NULL
TEL/AML1	NULL
protein	NULL
has	NULL
lost	NULL
the	NULL
Ets	NULL
DNA-binding	NULL
domain	NULL
of	NULL
TEL	NULL
,	NULL
but	NULL
still	NULL
contains	NULL
the	NULL
intact	NULL
AML1	NULL
DNA-binding	NULL
domain	NULL
,	NULL
this	NULL
fusion	NULL
protein	NULL
could	NULL
possibly	NULL
generate	NULL
leukemia	NULL
by	NULL
interfering	NULL
with	NULL
the	NULL
function	NULL
of	NULL
normal	NULL
AML1	NULL
or	NULL
other	NULL
PEBP2/CBEF	NULL
family	NULL
members	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
critical	NULL
B	NULL
cell	NULL
developmental	NULL
genes	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
searched	NULL
the	NULL
regulatory	NULL
regions	NULL
of	NULL
several	NULL
B	NULL
cell-specific	NULL
genes	NULL
for	NULL
putative	NULL
AML1-binding	NULL
sites	NULL
and	NULL
found	NULL
an	NULL
AML	NULL
1	NULL
binding	NULL
consensus	NULL
sequence	NULL
``	NULL
TGTGGT	NULL
``	NULL
in	NULL
the	NULL
B	NULL
cell-specific	NULL
bik	NULL
promoter	NULL
at	NULL
bp	NULL
-39	NULL
to	NULL
-34	NULL
,	NULL
just	NULL
downstream	NULL
of	NULL
the	NULL
BSAP-binding	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
putative	NULL
AML1	NULL
site	NULL
we	NULL
also	NULL
detected	NULL
putative	NULL
binding	NULL
sites	NULL
for	NULL
several	NULL
other	NULL
transcription	NULL
factors	NULL
including	NULL
three	NULL
putative	NULL
Ets-binding	NULL
sites	NULL
and	NULL
a	NULL
helix-loop-helix	NULL
protein-binding	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
AML1	NULL
can	NULL
interact	NULL
with	NULL
the	NULL
bik	NULL
promoter	NULL
,	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
AML1	NULL
consensus	NULL
sequence	NULL
from	NULL
the	NULL
bik	NULL
promoter	NULL
were	NULL
used	NULL
in	NULL
EMSA	NULL
experiments	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
B	NULL
cell	NULL
line	NULL
,	NULL
Ba/F3	NULL
,	NULL
or	NULL
with	NULL
in	NULL
vitro	NULL
translated	NULL
AML1L	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
Ba/F3	NULL
nuclear	NULL
extract	NULL
formed	NULL
a	NULL
specific	NULL
protein-DNA	NULL
complex	NULL
with	NULL
the	NULL
bik	NULL
promoter	NULL
bp	NULL
-47	NULL
to	NULL
-28	NULL
oligonucleotide	NULL
.	NULL

This	NULL
protein-DNA	NULL
complex	NULL
was	NULL
specifically	NULL
competed	NULL
by	NULL
unlabeled	NULL
self-oligonu-cleotide	NULL
or	NULL
an	NULL
oligonucleotide	NULL
encoding	NULL
the	NULL
Moloney	NULL
murine	NULL
leukemia	NULL
virus	NULL
enhancer	NULL
PEBP2/CBF-binding	NULL
site	NULL
(	NULL
50	NULL
)	NULL
,	NULL
but	NULL
not	NULL
by	NULL
an	NULL
unlabeled	NULL
non-PEBP2/CBF	NULL
binding	NULL
oligonucleotide	NULL
.	NULL

These	NULL
data	NULL
suggested	NULL
that	NULL
this	NULL
complex	NULL
contains	NULL
a	NULL
PEBP2/CBF	NULL
related	NULL
protein	NULL
.	NULL

To	NULL
further	NULL
characterize	NULL
this	NULL
protein	NULL
,	NULL
antiserum	NULL
raised	NULL
against	NULL
the	NULL
NH	NULL
,	NULL
-terminal	NULL
region	NULL
of	NULL
one	NULL
of	NULL
the	NULL
PEBP2/	NULL
CBF	NULL
family	NULL
members	NULL
,	NULL
AML1	NULL
(	NULL
46	NULL
)	NULL
,	NULL
was	NULL
used	NULL
in	NULL
the	NULL
EMSA	NULL
analysis	NULL
.	NULL

Upon	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
anti-AML1	NULL
antiserum	NULL
,	NULL
the	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
AML	NULL
1	NULL
Regulates	NULL
the	NULL
blk	NULL
Promoter	NULL
Antiserum	NULL
:	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
+	NULL
Competitor	NULL
:	NULL
-	NULL
-	NULL
S	NULL
CN	NULL
~	NULL
+	NULL
£4	NULL
44	NULL
eR	NULL
we	NULL
.4—	NULL
T	NULL
'	NULL
“	NULL
d—AMLI	NULL
k	NULL
.	NULL

RM	NULL
'	NULL
l	NULL
Nuclear	NULL
Extract	NULL
:	NULL
AML1I	NULL
+	NULL
CBFB	NULL
4-	NULL
T	NULL
L	NULL
an	NULL
,	NULL
“	NULL
<	NULL
-	NULL
AML	NULL
___	NULL
Lane	NULL
:	NULL
1	NULL
2	NULL
3	NULL
4	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Transcription	NULL
factor	NULL
AML1	NULL
binds	NULL
to	NULL
the	NULL
blk	NULL
promoter	NULL
.	NULL

The	NULL
bik	NULL
promoter	NULL
region	NULL
oligonucleotide	NULL
bp	NULL
-47	NULL
to	NULL
-28	NULL
was	NULL
*°P-labeled	NULL
and	NULL
incubated	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
double-stranded	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
either	NULL
nuclear	NULL
extracts	NULL
or	NULL
in	NULL
vitro	NULL
translated	NULL
proteins	NULL
.	NULL

A	NULL
,	NULL
labeled	NULL
oligonucleotide	NULL
was	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
nuclear	NULL
extracts	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
5	NULL
ug	NULL
of	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
the	NULL
B	NULL
cell	NULL
line	NULL
Ba/F3	NULL
(	NULL
Zanes	NULL
2-6	NULL
)	NULL
.	NULL

For	NULL
competition	NULL
analysis	NULL
,	NULL
50-fold	NULL
molar	NULL
excesses	NULL
of	NULL
unlabeled	NULL
blk	NULL
bp	NULL
-47	NULL
to	NULL
-28	NULL
oligonucleotide	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
,	NULL
AMLL	NULL
consensus-binding	NULL
site	NULL
oligonucleotide	NULL
from	NULL
Moloney	NULL
murine	NULL
leukemia	NULL
virus	NULL
enhancer	NULL
(	NULL
Zane	NULL
4	NULL
)	NULL
,	NULL
and	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
PU.1-binding	NULL
site	NULL
(	NULL
Fane	NULL
5	NULL
)	NULL
were	NULL
used	NULL
in	NULL
the	NULL
binding	NULL
reactions	NULL
.	NULL

In	NULL
lane	NULL
6	NULL
,	NULL
1	NULL
ul	NULL
of	NULL
anti-AML1	NULL
serum	NULL
was	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
.	NULL

B	NULL
,	NULL
in	NULL
vitro	NULL
translated	NULL
AML1	NULL
and	NULL
CBFB	NULL
were	NULL
used	NULL
in	NULL
the	NULL
bandshift	NULL
experiments	NULL
.	NULL

Radiolabeled	NULL
bik	NULL
promoter	NULL
oligonucleotide	NULL
was	NULL
incubated	NULL
with	NULL
2	NULL
ul	NULL
of	NULL
in	NULL
vitro	NULL
translation	NULL
reticulocyte	NULL
lysate	NULL
control	NULL
without	NULL
any	NULL
protein	NULL
expression	NULL
DNA	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
THP-1	NULL
cells	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
2	NULL
ul	NULL
of	NULL
in	NULL
vitro	NULL
translated	NULL
AML1	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
or	NULL
2	NULL
ul	NULL
of	NULL
in	NULL
vitro	NULL
translated	NULL
AML1	NULL
and	NULL
2	NULL
pl	NULL
of	NULL
in	NULL
vitro	NULL
translated	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

The	NULL
top	NULL
of	NULL
the	NULL
gel	NULL
(	NULL
T	NULL
)	NULL
,	NULL
the	NULL
migration	NULL
of	NULL
the	NULL
AMLI1-DNA	NULL
complex	NULL
(	NULL
AML1	NULL
)	NULL
,	NULL
and	NULL
the	NULL
free	NULL
probes	NULL
(	NULL
F	NULL
)	NULL
are	NULL
marked	NULL
on	NULL
the	NULL
right	NULL
of	NULL
each	NULL
panel	NULL
.	NULL

The	NULL
smaller	NULL
arrow	NULL
in	NULL
panel	NULL
A	NULL
marks	NULL
a	NULL
specific	NULL
DNA-protein	NULL
complex	NULL
,	NULL
which	NULL
is	NULL
either	NULL
CBFa-DNA	NULL
complex	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
CBF	NULL
$	NULL
S	NULL
or	NULL
with	NULL
degraded	NULL
CBF	NULL
proteins	NULL
.	NULL

*	NULL
in	NULL
panel	NULL
B	NULL
marks	NULL
the	NULL
nonspecific	NULL
shifted	NULL
bands	NULL
formed	NULL
with	NULL
endogenous	NULL
protein	NULL
in	NULL
unprogrammed	NULL
reticulocyte	NULL
lysate	NULL
or	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
THP-1	NULL
cells	NULL
.	NULL

specific	NULL
protein-DNA	NULL
complex	NULL
was	NULL
drastically	NULL
reduced	NULL
and	NULL
a	NULL
supershifted	NULL
band	NULL
was	NULL
detected	NULL
indicating	NULL
that	NULL
the	NULL
protein	NULL
in	NULL
Ba/F3	NULL
cell	NULL
nuclear	NULL
extracts	NULL
interacting	NULL
with	NULL
the	NULL
bik	NULL
promoter	NULL
AML1	NULL
site	NULL
is	NULL
either	NULL
identical	NULL
with	NULL
AML1	NULL
or	NULL
closely	NULL
related	NULL
.	NULL

Additional	NULL
EMSA	NULL
analysis	NULL
demonstrated	NULL
that	NULL
in	NULL
vitro	NULL
translated	NULL
AML	NULL
1	NULL
formed	NULL
a	NULL
complex	NULL
with	NULL
the	NULL
same	NULL
radiolabeled	NULL
bik	NULL
promoter	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
clearly	NULL
demonstrate	NULL
that	NULL
PEBP2/CBF	NULL
transcription	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
AML1	NULL
,	NULL
can	NULL
interact	NULL
specifically	NULL
with	NULL
the	NULL
bik	NULL
promoter	NULL
AML1	NULL
site	NULL
.	NULL

AML1	NULL
Induces	NULL
blk	NULL
Promoter	NULL
Transcription-To	NULL
determine	NULL
whether	NULL
the	NULL
AML1-binding	NULL
site	NULL
is	NULL
functionally	NULL
relevant	NULL
for	NULL
bik	NULL
promoter	NULL
activity	NULL
,	NULL
the	NULL
AML1	NULL
site	NULL
was	NULL
mutated	NULL
from	NULL
TGTGGT	NULL
24673	NULL
A	NULL
120	NULL
100	NULL
,	NULL
80	NULL
60	NULL
40	NULL
20	NULL
Promoter	NULL
Activity	NULL
(	NULL
%	NULL
)	NULL
7000	NULL
1	NULL
6000	NULL
5000	NULL
4000	NULL
3000	NULL
2000	NULL
1000	NULL
l	NULL
,	NULL
IM	NULL
H	NULL
|	NULL
a	NULL
AML	NULL
1+CBF	NULL
fk	NULL
+	NULL
Promoter	NULL
Activity	NULL
(	NULL
RLU	NULL
)	NULL
pBLK-Iuc	NULL
pBLK	NULL
(	NULL
mAML1	NULL
)	NULL
-lue	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

AML1	NULL
is	NULL
an	NULL
important	NULL
transcription	NULL
factor	NULL
for	NULL
blk	NULL
promoter	NULL
activity	NULL
.	NULL

A	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
AML1-binding	NULL
site	NULL
significantly	NULL
reduces	NULL
bik	NULL
promoter	NULL
activity	NULL
.	NULL

The	NULL
promoterless	NULL
pXP2	NULL
luciferase	NULL
con-struct	NULL
,	NULL
the	NULL
wild-type	NULL
blk	NULL
promoter-luciferase	NULL
construct	NULL
(	NULL
pBLK-luc	NULL
)	NULL
,	NULL
and	NULL
the	NULL
AML1	NULL
site	NULL
mutated	NULL
construct	NULL
(	NULL
pBLK	NULL
(	NULL
mAML1	NULL
)	NULL
-luc	NULL
)	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
B	NULL
cell	NULL
lines	NULL
BJA-B	NULL
(	NULL
®	NULL
)	NULL
and	NULL
Ba/F3	NULL
(	NULL
§	NULL
)	NULL
.	NULL

B	NULL
,	NULL
AML1	NULL
stimulates	NULL
transcription	NULL
from	NULL
the	NULL
blk	NULL
promoter	NULL
.	NULL

CV-1	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
the	NULL
Ca	NULL
,	NULL
(	NULL
POA4	NULL
)	NULL
,	NULL
precipitation	NULL
method	NULL
with	NULL
3.5	NULL
ug	NULL
of	NULL
the	NULL
wild	NULL
type	NULL
blk	NULL
promoter-luciferase	NULL
construct	NULL
(	NULL
pBLK-luc	NULL
)	NULL
or	NULL
the	NULL
AML1-binding	NULL
site	NULL
mutated	NULL
bik	NULL
promoter	NULL
construct	NULL
(	NULL
pBLK	NULL
(	NULL
mAML1	NULL
)	NULL
-luc	NULL
)	NULL
.	NULL

These	NULL
constructs	NULL
were	NULL
co-transfected	NULL
with	NULL
or	NULL
without	NULL
0.5	NULL
pg	NULL
each	NULL
of	NULL
AML1	NULL
and	NULL
its	NULL
heterodimer	NULL
partner	NULL
CBFS	NULL
expression	NULL
vector	NULL
pCMV-AMLIB	NULL
and	NULL
pCMV-CBF	NULL
$	NULL
S	NULL
.	NULL

The	NULL
averages	NULL
and	NULL
standard	NULL
deviations	NULL
were	NULL
generated	NULL
from	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

Luciferase	NULL
activities	NULL
were	NULL
normalized	NULL
for	NULL
transfection	NULL
efficiency	NULL
with	NULL
the	NULL
co-transfected	NULL
growth	NULL
hormone	NULL
plasmid	NULL
Rous	NULL
sarcoma	NULL
virus-human	NULL
growth	NULL
hormone	NULL
.	NULL

The	NULL
error	NULL
bars	NULL
indicate	NULL
the	NULL
mean	NULL
+	NULL
S.D	NULL
.	NULL

to	NULL
TGCACT	NULL
in	NULL
the	NULL
bik	NULL
promoter	NULL
luciferase	NULL
construct	NULL
to	NULL
generate	NULL
pBlk	NULL
(	NULL
mAML1	NULL
)	NULL
-lue	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
transient	NULL
transfection	NULL
into	NULL
the	NULL
B	NULL
cell	NULL
line	NULL
BJA-B	NULL
demonstrated	NULL
that	NULL
the	NULL
bik	NULL
gene	NULL
upstream	NULL
region	NULL
from	NULL
bp	NULL
-191	NULL
to	NULL
+136	NULL
has	NULL
strong	NULL
promoter	NULL
activity	NULL
as	NULL
previously	NULL
shown	NULL
(	NULL
33	NULL
)	NULL
.	NULL

A	NULL
25-fold	NULL
increase	NULL
in	NULL
luciferase	NULL
expression	NULL
was	NULL
observed	NULL
in	NULL
comparison	NULL
to	NULL
the	NULL
promoterless	NULL
luciferase	NULL
construct	NULL
pXP2	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
AML1-binding	NULL
site	NULL
in	NULL
the	NULL
bik	NULL
promoter	NULL
reduced	NULL
the	NULL
promoter	NULL
activity	NULL
to	NULL
67	NULL
%	NULL
when	NULL
compared	NULL
with	NULL
the	NULL
wild	NULL
type	NULL
promoter	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
same	NULL
mutation	NULL
also	NULL
reduced	NULL
the	NULL
promoter	NULL
activity	NULL
to	NULL
a	NULL
similar	NULL
level	NULL
in	NULL
another	NULL
B	NULL
cell	NULL
line	NULL
,	NULL
Ba/F3	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
the	NULL
AML1-binding	NULL
site	NULL
in	NULL
the	NULL
bik	NULL
promoter	NULL
is	NULL
a	NULL
functionally	NULL
relevant	NULL
site	NULL
,	NULL
although	NULL
not	NULL
absolutely	NULL
essential	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
AML1	NULL
can	NULL
indeed	NULL
transactivate	NULL
the	NULL
bik	NULL
promoter	NULL
,	NULL
co-transfec-tion	NULL
experiments	NULL
were	NULL
performed	NULL
in	NULL
CV-1	NULL
cells	NULL
with	NULL
expression	NULL
vectors	NULL
for	NULL
AML1	NULL
and	NULL
its	NULL
heterodimer	NULL
partner	NULL
CBF	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
exogenous	NULL
AML1	NULL
together	NULL
with	NULL
CBFRG	NULL
expression	NULL
increases	NULL
transcription	NULL
of	NULL
the	NULL
wild	NULL
type	NULL
bik	NULL
promoter-luciferase	NULL
construct	NULL
by	NULL
7-fold	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
AML1-binding	NULL
site	NULL
reduced	NULL
transactivation	NULL
of	NULL
the	NULL
bik	NULL
promoter	NULL
by	NULL
AMLUVCBEF	NULL
to	NULL
less	NULL
than	NULL
2-fold	NULL
.	NULL

These	NULL
data	NULL
together	NULL
with	NULL
the	NULL
results	NULL
from	NULL
the	NULL
DNA-protein	NULL
interaction	NULL
studies	NULL
demonstrate	NULL
that	NULL
AML1	NULL
or	NULL
a	NULL
related	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
24674	NULL
AML	NULL
1	NULL
Regulates	NULL
the	NULL
blk	NULL
Promoter	NULL
A	NULL
runt	NULL
transactivation	NULL
87	NULL
domain	NULL
204	NULL
d	NULL
479	NULL
omain	NULL
_	NULL
AML1	NULL
___	NULL
Maza	NULL
oma	NULL
|	NULL
Lina	NULL
aes	NULL
,	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

AML1	NULL
physically	NULL
interacts	NULL
with	NULL
BSAP	NULL
.	NULL

Panel	NULL
A	NULL
shows	NULL
the	NULL
domain	NULL
structure	NULL
of	NULL
AML1	NULL
and	NULL
BSAP	NULL
.	NULL

The	NULL
details	NULL
of	NULL
the	NULL
constructions	NULL
are	NULL
described	NULL
under	NULL
16	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

Five	NULL
ul	NULL
of	NULL
in	NULL
vitro	NULL
translated	NULL
(	NULL
IVT	NULL
)	NULL
,	NULL
``	NULL
°S-labeled	NULL
full-length	NULL
AML1	NULL
(	NULL
panel	NULL
B	NULL
)	NULL
,	NULL
NH-terminal	NULL
portion	NULL
of	NULL
AML1	NULL
(	NULL
panel	NULL
C	NULL
)	NULL
,	NULL
or	NULL
AML1	NULL
runt	NULL
homology	NULL
domain	NULL
(	NULL
panel	NULL
D	NULL
)	NULL
were	NULL
loaded	NULL
on	NULL
the	NULL
gel	NULL
and	NULL
served	NULL
as	NULL
positive	NULL
controls	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
or	NULL
incubated	NULL
with	NULL
E.	NULL
coli-produced	NULL
GST	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
,	NULL
and	NULL
GST-BSAP	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
immobilized	NULL
on	NULL
glutathione-agarose	NULL
beads	NULL
.	NULL

Panel	NULL
E	NULL
,	NULL
5	NULL
ul	NULL
of	NULL
in	NULL
vitro	NULL
translated	NULL
,	NULL
°°9-labeled	NULL
full-length	NULL
AML1	NULL
was	NULL
directly	NULL
loaded	NULL
on	NULL
the	NULL
gel	NULL
(	NULL
IVT	NULL
;	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
incubated	NULL
with	NULL
E.	NULL
coli-produced	NULL
GST	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
,	NULL
GST	NULL
BSAP|_	NULL
;	NULL
;	NULL
,	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
,	NULL
GST-BSAP	NULL
;	NULL
;	NULL
;	NULL
,	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
or	NULL
GST-BSAP	NULL
;	NULL
;	NULL
,	NULL
39	NULL
,	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
immobi-	NULL
lized	NULL
on	NULL
glutathione-agarose	NULL
beads	NULL
.	NULL

B	NULL
Bound	NULL
proteins	NULL
were	NULL
analyzed	NULL
in	NULL
SDS-	NULL
polyacrylamide	NULL
gels	NULL
and	NULL
were	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

AML	NULL
paired	NULL
domain	NULL
iss	NULL
GST-BSAP	NULL
IVT	NULL
G	NULL
<	NULL
-AML1	NULL
wseee	NULL
g	NULL
1	NULL
2	NULL
3	NULL
family	NULL
member	NULL
plays	NULL
a	NULL
significant	NULL
role	NULL
in	NULL
B	NULL
cell-specific	NULL
regulation	NULL
of	NULL
the	NULL
bik	NULL
promoter	NULL
.	NULL

AML1	NULL
Physically	NULL
Interacts	NULL
with	NULL
BSAP-As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
the	NULL
AML1-binding	NULL
site	NULL
is	NULL
relatively	NULL
close	NULL
to	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
of	NULL
the	NULL
bik	NULL
gene	NULL
.	NULL

Six	NULL
base	NULL
pairs	NULL
upstream	NULL
of	NULL
the	NULL
AML1	NULL
site	NULL
is	NULL
a	NULL
region	NULL
that	NULL
has	NULL
been	NULL
identified	NULL
as	NULL
a	NULL
BSAP-binding	NULL
site	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

BSAP	NULL
is	NULL
a	NULL
B	NULL
cell-specific	NULL
activating	NULL
protein	NULL
,	NULL
which	NULL
is	NULL
a	NULL
critical	NULL
transcription	NULL
factor	NULL
for	NULL
B	NULL
cell-specific	NULL
gene	NULL
expression	NULL
and	NULL
B	NULL
cell	NULL
development	NULL
.	NULL

Since	NULL
AML1	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
interact	NULL
and	NULL
cooperate	NULL
with	NULL
other	NULL
transcription	NULL
factors	NULL
,	NULL
and	NULL
the	NULL
AML1	NULL
site	NULL
is	NULL
adjacent	NULL
to	NULL
the	NULL
BSAP-binding	NULL
site	NULL
,	NULL
we	NULL
analyzed	NULL
whether	NULL
AML1	NULL
can	NULL
cooperate	NULL
with	NULL
BSAP	NULL
in	NULL
regulating	NULL
bik	NULL
gene	NULL
expression	NULL
.	NULL

First	NULL
,	NULL
we	NULL
studied	NULL
their	NULL
physical	NULL
interaction	NULL
using	NULL
GST-pull	NULL
down	NULL
assays	NULL
,	NULL
in	NULL
which	NULL
Escherichia	NULL
coli	NULL
expressing	NULL
GST	NULL
fusion	NULL
proteins	NULL
immobilized	NULL
on	NULL
glutathione-agarose	NULL
beads	NULL
were	NULL
incubated	NULL
with	NULL
in	NULL
vitro	NULL
translated	NULL
°°S-labeled	NULL
proteins	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
in	NULL
vitro	NULL
translated	NULL
full-length	NULL
AML1l	NULL
can	NULL
be	NULL
specifically	NULL
retained	NULL
on	NULL
agarose	NULL
beads	NULL
containing	NULL
the	NULL
fusion	NULL
protein	NULL
made	NULL
from	NULL
BSAP	NULL
(	NULL
GST-BSAP	NULL
)	NULL
,	NULL
but	NULL
not	NULL
on	NULL
glutathione	NULL
beads	NULL
containing	NULL
only	NULL
GST	NULL
.	NULL

This	NULL
result	NULL
indicates	NULL
that	NULL
AML1	NULL
can	NULL
physically	NULL
interact	NULL
with	NULL
BSAP	NULL
.	NULL

To	NULL
analyze	NULL
this	NULL
interaction	NULL
in	NULL
more	NULL
detail	NULL
,	NULL
DNA	NULL
constructs	NULL
containing	NULL
only	NULL
the	NULL
NH-terminal	NULL
portion	NULL
of	NULL
AML1	NULL
(	NULL
a.a.	NULL
1-208	NULL
)	NULL
or	NULL
the	NULL
AML	NULL
1	NULL
runt	NULL
homology	NULL
domain	NULL
(	NULL
a.a.	NULL
87-208	NULL
)	NULL
were	NULL
in	NULL
vitro	NULL
translated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
®°S	NULL
)	NULL
methionine	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

AML1	NULL
papy	NULL
AML1g7.205	NULL
homeodomain	NULL
|	NULL
transactivation	NULL
homology	NULL
domain	NULL
143	NULL
229	NULL
251	NULL
304	NULL
358	NULL
_	NULL
391	NULL
]	NULL
|	NULL
|	NULL
|	NULL
|	NULL
|	NULL
|	NULL
__	NULL
BSAP	NULL
7	NULL
|	NULL
BSAP	NULL
;	NULL
;	NULL
;	NULL
;	NULL
BSAP	NULL
;	NULL
js	NULL
,	NULL
BSAP234-391	NULL
C	NULL
D	NULL
E	NULL
AML1	NULL
AML1	NULL
1.309	NULL
AML1g7.3203	NULL
a	NULL
g	NULL
5	NULL
2	NULL
PM	NULL
a	NULL
eZ	NULL
af	NULL
pe	NULL
#	NULL
a	NULL
d	NULL
4	NULL
po	NULL
&	NULL
o	NULL
&	NULL
&	NULL
8	NULL
8	NULL
2	NULL
&	NULL
m	NULL
2	NULL
a	NULL
a	NULL
al	NULL
E	NULL
5	NULL
5	NULL
R	NULL
2	NULL
3	NULL
0	NULL
&	NULL
0	NULL
$	NULL
2	NULL
-	NULL
38	NULL
3	NULL
3	NULL
a	NULL
a	NULL
:	NULL
Falzﬂuﬂéil	NULL
)	NULL
-	NULL
-we	NULL
<	NULL
-AML1	NULL
wage	NULL
c	NULL
Hole	NULL
.	NULL

cam	NULL
<	NULL
-AML1	NULL
.s	NULL
(	NULL
87-208	NULL
)	NULL
Toot	NULL
``	NULL
1	NULL
2	NULL
3	NULL
1	NULL
2	NULL
3	NULL
1	NULL
2	NULL
3	NULL
4	NULL
S	NULL
4	NULL
,	NULL
B	NULL
and	NULL
C	NULL
,	NULL
both	NULL
peptides	NULL
can	NULL
specifically	NULL
interact	NULL
with	NULL
GST-BSAP	NULL
fusion	NULL
protein	NULL
,	NULL
but	NULL
not	NULL
GST	NULL
protein	NULL
alone	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
runt	NULL
homology	NULL
domain	NULL
of	NULL
AML1	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
interaction	NULL
with	NULL
BSAP	NULL
.	NULL

To	NULL
determine	NULL
which	NULL
domain	NULL
of	NULL
BSAP	NULL
is	NULL
responsible	NULL
for	NULL
its	NULL
interaction	NULL
with	NULL
AML1	NULL
,	NULL
GST-fusion	NULL
proteins	NULL
containing	NULL
COOH-terminal	NULL
deletion	NULL
mutants	NULL
of	NULL
BSAP	NULL
were	NULL
used	NULL
in	NULL
the	NULL
binding	NULL
reactions	NULL
.	NULL

Removal	NULL
of	NULL
the	NULL
carboxyl	NULL
terminus	NULL
up	NULL
to	NULL
a.a.	NULL
312	NULL
did	NULL
not	NULL
have	NULL
any	NULL
effect	NULL
on	NULL
AML1L	NULL
interaction	NULL
(	NULL
Fig	NULL
.	NULL

46	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

The	NULL
BSAP	NULL
NH	NULL
,	NULL
-terminal	NULL
portion	NULL
(	NULL
a.a.	NULL
1-159	NULL
)	NULL
containing	NULL
the	NULL
paired	NULL
DNA-binding	NULL
domain	NULL
retained	NULL
the	NULL
interaction	NULL
with	NULL
AML1	NULL
as	NULL
well	NULL
(	NULL
Fig	NULL
.	NULL

46	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
GST	NULL
-fusion	NULL
protein	NULL
containing	NULL
only	NULL
the	NULL
BSAP	NULL
COOH-terminal	NULL
portion	NULL
(	NULL
a.a.	NULL
234-391	NULL
)	NULL
did	NULL
not	NULL
show	NULL
any	NULL
interaction	NULL
with	NULL
AML1	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
AML1	NULL
can	NULL
directly	NULL
interact	NULL
with	NULL
BSAP	NULL
and	NULL
this	NULL
interaction	NULL
is	NULL
through	NULL
the	NULL
runt	NULL
homology	NULL
domain	NULL
of	NULL
AML1	NULL
and	NULL
the	NULL
paired	NULL
domain	NULL
of	NULL
BSAP	NULL
(	NULL
6	NULL
,	NULL
42	NULL
,	NULL
51	NULL
)	NULL
.	NULL

AML1	NULL
Cooperates	NULL
with	NULL
BSAP	NULL
in	NULL
Transactivation	NULL
of	NULL
the	NULL
blk	NULL
Promoter-Both	NULL
AML1l-binding	NULL
site	NULL
mutation	NULL
analysis	NULL
and	NULL
transactivation	NULL
analysis	NULL
indicate	NULL
that	NULL
AML1	NULL
is	NULL
an	NULL
important	NULL
transcription	NULL
factor	NULL
for	NULL
bik	NULL
promoter	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

BSAP	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
a	NULL
critical	NULL
regulator	NULL
of	NULL
bik	NULL
promoter	NULL
activity	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
and	NULL
data	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
have	NULL
demonstrated	NULL
the	NULL
physical	NULL
interaction	NULL
between	NULL
these	NULL
two	NULL
transcription	NULL
factors	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
physical	NULL
interaction	NULL
between	NULL
AML1	NULL
and	NULL
BSAP	NULL
is	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
AML	NULL
1	NULL
Regulates	NULL
the	NULL
blk	NULL
Promoter	NULL
Control	NULL
BSAP	NULL
AML1	NULL
+	NULL
CBFB	NULL
BSAP	NULL
+	NULL
AML1	NULL
+	NULL
CBFR	NULL
0	NULL
20	NULL
40	NULL
60	NULL
Promoter	NULL
Activity	NULL
(	NULL
Fold	NULL
of	NULL
Activation	NULL
)	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

AML1	NULL
and	NULL
BSAP	NULL
synergistically	NULL
activate	NULL
the	NULL
blk	NULL
promoter	NULL
.	NULL

CV-1	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
the	NULL
Ca	NULL
,	NULL
(	NULL
PO	NULL
,	NULL
)	NULL
,	NULL
precipitation	NULL
method	NULL
with	NULL
3.5	NULL
ug	NULL
of	NULL
blk	NULL
promoter-luciferase	NULL
construct	NULL
(	NULL
pBLK-luc	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
0.5	NULL
ug	NULL
of	NULL
the	NULL
AML1	NULL
,	NULL
CBFB	NULL
,	NULL
and	NULL
BSAP	NULL
expression	NULL
constructs	NULL
pCMV-AML1B	NULL
,	NULL
pCMV-CBF	NULL
$	NULL
,	NULL
or	NULL
pCI-BSAP	NULL
,	NULL
re-spectively	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
averages	NULL
and	NULL
standard	NULL
deviations	NULL
were	NULL
generated	NULL
from	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

Luciferase	NULL
activities	NULL
were	NULL
normalized	NULL
for	NULL
transfection	NULL
efficiency	NULL
with	NULL
the	NULL
co-transfected	NULL
growth	NULL
hormone	NULL
plasmid	NULL
Rous	NULL
sarcoma	NULL
virus-human	NULL
growth	NULL
hormone	NULL
.	NULL

The	NULL
error	NULL
bars	NULL
indicate	NULL
the	NULL
mean	NULL
+	NULL
S.D	NULL
.	NULL

Fold	NULL
increases	NULL
in	NULL
the	NULL
promoter	NULL
activity	NULL
are	NULL
relative	NULL
to	NULL
that	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
additional	NULL
transcription	NULL
factors	NULL
.	NULL

associated	NULL
with	NULL
functional	NULL
cooperativity	NULL
in	NULL
activating	NULL
bik	NULL
gene	NULL
expression	NULL
,	NULL
we	NULL
performed	NULL
co-transactivation	NULL
experiments	NULL
in	NULL
monkey	NULL
kidney	NULL
CV-1	NULL
cells	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
only	NULL
the	NULL
parental	NULL
expression	NULL
vector	NULL
(	NULL
control	NULL
)	NULL
,	NULL
luciferase	NULL
expression	NULL
directed	NULL
by	NULL
the	NULL
bik	NULL
promoter	NULL
is	NULL
~2-fold	NULL
over	NULL
the	NULL
promoterless	NULL
construct	NULL
.	NULL

When	NULL
BSAP	NULL
was	NULL
used	NULL
alone	NULL
in	NULL
the	NULL
transactivation	NULL
experiments	NULL
,	NULL
there	NULL
was	NULL
an	NULL
8-fold	NULL
induction	NULL
of	NULL
bik	NULL
promoter	NULL
activity	NULL
.	NULL

AML1	NULL
together	NULL
with	NULL
its	NULL
heterodimer	NULL
partner	NULL
CBFB	NULL
activated	NULL
the	NULL
bik	NULL
promoter	NULL
12-fold	NULL
.	NULL

When	NULL
all	NULL
three	NULL
transcription	NULL
factors	NULL
,	NULL
BSAP	NULL
,	NULL
AML1	NULL
,	NULL
and	NULL
CBFB	NULL
were	NULL
used	NULL
in	NULL
the	NULL
same	NULL
transactivation	NULL
experiment	NULL
,	NULL
bik	NULL
promoter	NULL
activity	NULL
was	NULL
induced	NULL
by	NULL
51-fold	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
a	NULL
strong	NULL
transcriptional	NULL
synergy	NULL
of	NULL
bik	NULL
promoter	NULL
activity	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
all	NULL
three	NULL
factors	NULL
,	NULL
indicating	NULL
that	NULL
physical	NULL
interaction	NULL
between	NULL
AML1L	NULL
and	NULL
BSAP	NULL
leads	NULL
to	NULL
functional	NULL
cooperativity	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
bik	NULL
promoter	NULL
.	NULL

DISCUSSION	NULL
AML1	NULL
is	NULL
a	NULL
transcription	NULL
factor	NULL
identified	NULL
by	NULL
studying	NULL
t	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
associated	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
(	NULL
1	NULL
,	NULL
52-54	NULL
)	NULL
.	NULL

The	NULL
function	NULL
of	NULL
AML1	NULL
in	NULL
hematopoiesis	NULL
has	NULL
been	NULL
demonstrated	NULL
by	NULL
analyzing	NULL
its	NULL
role	NULL
in	NULL
regulating	NULL
the	NULL
expression	NULL
of	NULL
critical	NULL
hematopoietic	NULL
genes	NULL
and	NULL
by	NULL
studying	NULL
AML	NULL
1	NULL
null	NULL
mice	NULL
(	NULL
55	NULL
,	NULL
56	NULL
)	NULL
.	NULL

AML1	NULL
knockout	NULL
mice	NULL
die	NULL
during	NULL
embryogenesis	NULL
with	NULL
the	NULL
block	NULL
of	NULL
definitive	NULL
hematopoiesis	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
indicate	NULL
that	NULL
AML1	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
during	NULL
early	NULL
hematopoietic	NULL
progenitor	NULL
cell	NULL
formation	NULL
.	NULL

AML1	NULL
binds	NULL
to	NULL
the	NULL
regulatory	NULL
elements	NULL
of	NULL
genes	NULL
specifically	NULL
expressed	NULL
in	NULL
different	NULL
lineages	NULL
of	NULL
hematopoietic	NULL
cells	NULL
or	NULL
of	NULL
genes	NULL
important	NULL
for	NULL
lineage	NULL
development	NULL
.	NULL

Recently	NULL
,	NULL
AML1	NULL
has	NULL
been	NULL
found	NULL
to	NULL
associate	NULL
with	NULL
a	NULL
chromosomal	NULL
trans-location	NULL
,	NULL
t	NULL
(	NULL
12	NULL
;	NULL
21	NULL
)	NULL
,	NULL
commonly	NULL
associated	NULL
with	NULL
B-cell	NULL
lineage	NULL
differentiation	NULL
,	NULL
indicating	NULL
an	NULL
important	NULL
role	NULL
for	NULL
AML	NULL
1	NULL
during	NULL
B	NULL
cell	NULL
development	NULL
(	NULL
20	NULL
,	NULL
22	NULL
)	NULL
.	NULL

Nevertheless	NULL
,	NULL
only	NULL
one	NULL
potential	NULL
B	NULL
cell-specific	NULL
target	NULL
gene	NULL
for	NULL
AML1	NULL
,	NULL
the	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
gene	NULL
enhancer	NULL
(	NULL
57	NULL
)	NULL
,	NULL
has	NULL
been	NULL
identified	NULL
to	NULL
date	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
decided	NULL
to	NULL
search	NULL
for	NULL
other	NULL
potential	NULL
target	NULL
genes	NULL
for	NULL
AML1	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

We	NULL
identified	NULL
a	NULL
putative	NULL
AML1-binding	NULL
site	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
B	NULL
cell-specific	NULL
bik	NULL
gene	NULL
and	NULL
tested	NULL
the	NULL
potential	NULL
role	NULL
of	NULL
AML	NULL
1	NULL
in	NULL
B-cell	NULL
specific	NULL
bik	NULL
gene	NULL
regulation	NULL
.	NULL

We	NULL
provide	NULL
strong	NULL
evidence	NULL
here	NULL
that	NULL
AML1	NULL
directly	NULL
interacts	NULL
with	NULL
a	NULL
functionally	NULL
important	NULL
region	NULL
of	NULL
the	NULL
bik	NULL
promoter	NULL
and	NULL
transactivates	NULL
the	NULL
promoter	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
AML1	NULL
physically	NULL
interacts	NULL
with	NULL
another	NULL
critical	NULL
B-cell	NULL
transcription	NULL
factor	NULL
BSAP	NULL
and	NULL
synergizes	NULL
with	NULL
BSAP	NULL
in	NULL
regu-	NULL
24675	NULL
lating	NULL
bik	NULL
promoter	NULL
activity	NULL
.	NULL

There	NULL
are	NULL
different	NULL
alternatively	NULL
spliced	NULL
forms	NULL
of	NULL
AML1	NULL
,	NULL
which	NULL
have	NULL
been	NULL
named	NULL
as	NULL
AML1L	NULL
(	NULL
AML1a	NULL
)	NULL
,	NULL
AMLIA	NULL
(	NULL
AML1b	NULL
)	NULL
,	NULL
and	NULL
AML1B	NULL
(	NULL
AML1c	NULL
)	NULL
.	NULL

In	NULL
this	NULL
pa-per	NULL
,	NULL
we	NULL
used	NULL
``	NULL
AML1	NULL
``	NULL
to	NULL
include	NULL
different	NULL
forms	NULL
of	NULL
the	NULL
AML1L	NULL
protein	NULL
.	NULL

AMLIB	NULL
was	NULL
used	NULL
in	NULL
the	NULL
transactivation	NULL
and	NULL
in	NULL
vitro	NULL
transcription	NULL
reactions	NULL
.	NULL

AML1	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
CBF	NULL
protein	NULL
family	NULL
.	NULL

All	NULL
three	NULL
a	NULL
subunits	NULL
of	NULL
the	NULL
CBF	NULL
family	NULL
contain	NULL
the	NULL
highly	NULL
conserved	NULL
runt	NULL
homology	NULL
domain	NULL
,	NULL
which	NULL
encodes	NULL
the	NULL
DNA-binding	NULL
domain	NULL
.	NULL

Therefore	NULL
,	NULL
all	NULL
three	NULL
a	NULL
subunits	NULL
recognize	NULL
the	NULL
same	NULL
``	NULL
TGTGGT	NULL
``	NULL
DNA	NULL
sequence	NULL
.	NULL

Previous	NULL
studies	NULL
by	NULL
others	NULL
have	NULL
identified	NULL
different	NULL
members	NULL
of	NULL
the	NULL
CBFa	NULL
protein	NULL
in	NULL
B	NULL
cell	NULL
lines	NULL
and	NULL
a	NULL
B	NULL
cell-enriched	NULL
tissue	NULL
spleen	NULL
,	NULL
using	NULL
antibodies	NULL
specifically	NULL
against	NULL
three	NULL
different	NULL
CBFa	NULL
subunits	NULL
.	NULL

Their	NULL
results	NULL
show	NULL
that	NULL
AML1	NULL
and	NULL
AML2	NULL
are	NULL
expressed	NULL
at	NULL
similar	NULL
levels	NULL
in	NULL
B	NULL
lineage	NULL
cells	NULL
;	NULL
AML3	NULL
is	NULL
not	NULL
detectable	NULL
(	NULL
58	NULL
)	NULL
.	NULL

The	NULL
AML1	NULL
antiserum	NULL
that	NULL
we	NULL
used	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
is	NULL
raised	NULL
against	NULL
the	NULL
AML1	NULL
NH	NULL
,	NULL
-terminal	NULL
17	NULL
amino	NULL
acids	NULL
.	NULL

The	NULL
NH	NULL
,	NULL
-terminal	NULL
region	NULL
is	NULL
conserved	NULL
between	NULL
all	NULL
three	NULL
CBFa	NULL
proteins	NULL
.	NULL

Since	NULL
both	NULL
AML1	NULL
and	NULL
AML2	NULL
are	NULL
expressed	NULL
at	NULL
similar	NULL
levels	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
both	NULL
AML1	NULL
and	NULL
AML2	NULL
have	NULL
a	NULL
similar	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
58	NULL
)	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
both	NULL
of	NULL
them	NULL
are	NULL
in	NULL
the	NULL
supershifted	NULL
protein-DNA	NULL
complex	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

It	NULL
has	NULL
been	NULL
reported	NULL
previously	NULL
that	NULL
CBFB	NULL
enhances	NULL
AML1L	NULL
binding	NULL
to	NULL
DNA	NULL
(	NULL
3	NULL
)	NULL
and	NULL
CBFB-AML1	NULL
forms	NULL
a	NULL
slower	NULL
mobility	NULL
shifted	NULL
band	NULL
with	NULL
DNA	NULL
than	NULL
AMLI-DNA	NULL
complex	NULL
(	NULL
46	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
in	NULL
vitro	NULL
translated	NULL
AML1	NULL
binds	NULL
to	NULL
DNA	NULL
and	NULL
addition	NULL
of	NULL
CBFB	NULL
enhances	NULL
the	NULL
binding	NULL
of	NULL
AML1	NULL
with	NULL
the	NULL
DNA	NULL
.	NULL

However	NULL
,	NULL
we	NULL
did	NULL
not	NULL
detect	NULL
an	NULL
obvious	NULL
slower	NULL
mobility	NULL
complex	NULL
.	NULL

This	NULL
is	NULL
probably	NULL
due	NULL
to	NULL
the	NULL
lack	NULL
of	NULL
a	NULL
particular	NULL
modification	NULL
in	NULL
the	NULL
in	NULL
vitro	NULL
translation	NULL
system	NULL
that	NULL
is	NULL
required	NULL
for	NULL
forming	NULL
a	NULL
stable	NULL
complex	NULL
of	NULL
a	NULL
heterodimer	NULL
CBF	NULL
protein	NULL
with	NULL
DNA	NULL
,	NULL
or	NULL
the	NULL
specific	NULL
experimental	NULL
conditions	NULL
do	NULL
not	NULL
favor	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
complex	NULL
during	NULL
gel	NULL
electrophoresis	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
AML	NULL
1	NULL
site	NULL
in	NULL
the	NULL
bik	NULL
promoter	NULL
significantly	NULL
reduced	NULL
promoter	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
this	NULL
mutation	NULL
did	NULL
not	NULL
abolish	NULL
the	NULL
promoter	NULL
activity	NULL
,	NULL
indicating	NULL
that	NULL
AML1	NULL
is	NULL
an	NULL
important	NULL
factor	NULL
for	NULL
the	NULL
promoter	NULL
activity	NULL
.	NULL

Other	NULL
transcription	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
bik	NULL
promoter	NULL
could	NULL
also	NULL
contribute	NULL
to	NULL
the	NULL
promoter	NULL
activity	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
besides	NULL
the	NULL
AML1L-binding	NULL
site	NULL
,	NULL
there	NULL
are	NULL
several	NULL
other	NULL
potential	NULL
transcription	NULL
factor-binding	NULL
sites	NULL
including	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
B	NULL
cell-specific	NULL
BSAP	NULL
transcription	NULL
factor	NULL
just	NULL
upstream	NULL
of	NULL
the	NULL
AMLL	NULL
site	NULL
.	NULL

BSAP	NULL
has	NULL
been	NULL
reported	NULL
previously	NULL
to	NULL
play	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
bik	NULL
promoter	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
analyzed	NULL
whether	NULL
AML1	NULL
and	NULL
BSAP	NULL
could	NULL
interact	NULL
with	NULL
each	NULL
other	NULL
and	NULL
whether	NULL
there	NULL
is	NULL
any	NULL
synergy	NULL
between	NULL
these	NULL
two	NULL
factors	NULL
in	NULL
promoter	NULL
activation	NULL
.	NULL

The	NULL
results	NULL
from	NULL
GST-pull	NULL
down	NULL
assays	NULL
demonstrated	NULL
a	NULL
strong	NULL
interaction	NULL
between	NULL
these	NULL
two	NULL
factors	NULL
,	NULL
and	NULL
the	NULL
interaction	NULL
is	NULL
between	NULL
the	NULL
AML1	NULL
runt	NULL
homology	NULL
domain	NULL
and	NULL
the	NULL
BSAP	NULL
paired	NULL
domain	NULL
.	NULL

The	NULL
original	NULL
function	NULL
of	NULL
the	NULL
runt	NULL
homology	NULL
domain	NULL
includes	NULL
direct	NULL
binding	NULL
to	NULL
DNA	NULL
and	NULL
formation	NULL
of	NULL
heterodimers	NULL
with	NULL
CBFB	NULL
.	NULL

There	NULL
have	NULL
been	NULL
reports	NULL
about	NULL
AML1	NULL
physically	NULL
interacting	NULL
with	NULL
other	NULL
transcription	NULL
factors	NULL
through	NULL
the	NULL
runt	NULL
homology	NULL
domain	NULL
,	NULL
including	NULL
Ets-1	NULL
,	NULL
PU.1	NULL
,	NULL
and	NULL
CAAT/enhancer-binding	NULL
protein	NULL
family	NULL
members	NULL
(	NULL
14	NULL
,	NULL
48	NULL
,	NULL
49	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
paired	NULL
domain	NULL
of	NULL
BSAP	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
protein-protein	NULL
interactions	NULL
with	NULL
members	NULL
of	NULL
the	NULL
Ets	NULL
family	NULL
(	NULL
59	NULL
)	NULL
.	NULL

The	NULL
interaction	NULL
between	NULL
AML1	NULL
and	NULL
BSAP	NULL
represents	NULL
a	NULL
new	NULL
class	NULL
of	NULL
interaction	NULL
between	NULL
AML1	NULL
and	NULL
other	NULL
transcription	NULL
factors	NULL
.	NULL

Interestingly	NULL
,	NULL
it	NULL
is	NULL
the	NULL
DNA-binding	NULL
domain	NULL
that	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
interaction	NULL
of	NULL
both	NULL
transcription	NULL
factors	NULL
.	NULL

It	NULL
will	NULL
be	NULL
interesting	NULL
to	NULL
further	NULL
study	NULL
the	NULL
specific	NULL
amino	NULL
acids	NULL
involved	NULL
in	NULL
the	NULL
different	NULL
interactions	NULL
.	NULL

The	NULL
interaction	NULL
and	NULL
synergy	NULL
between	NULL
Ets-1	NULL
and	NULL
AML1	NULL
is	NULL
crucial	NULL
for	NULL
the	NULL
enhancer	NULL
function	NULL
of	NULL
several	NULL
T	NULL
cell	NULL
receptor	NULL
genes	NULL
(	NULL
14	NULL
,	NULL
60	NULL
)	NULL
;	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
24676	NULL
furthermore	NULL
,	NULL
the	NULL
interactions	NULL
and	NULL
synergies	NULL
between	NULL
AML1L	NULL
and	NULL
PU.1	NULL
(	NULL
49	NULL
)	NULL
,	NULL
Myb	NULL
(	NULL
61	NULL
)	NULL
,	NULL
and	NULL
CAAT/enhancer-binding	NULL
protein	NULL
(	NULL
48	NULL
)	NULL
have	NULL
been	NULL
demonstrated	NULL
to	NULL
serve	NULL
critical	NULL
functions	NULL
during	NULL
activation	NULL
of	NULL
myeloid	NULL
specific	NULL
gene	NULL
expression	NULL
.	NULL

Both	NULL
AML1	NULL
and	NULL
BSAP	NULL
are	NULL
critical	NULL
regulators	NULL
of	NULL
hematopoiesis	NULL
(	NULL
16	NULL
,	NULL
17	NULL
,	NULL
62	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
both	NULL
genes	NULL
have	NULL
been	NULL
directly	NULL
implicated	NULL
in	NULL
B	NULL
cell	NULL
malignancies	NULL
(	NULL
20	NULL
,	NULL
63	NULL
)	NULL
.	NULL

The	NULL
interaction	NULL
and	NULL
synergy	NULL
between	NULL
AML1	NULL
and	NULL
BSAP	NULL
could	NULL
play	NULL
a	NULL
significant	NULL
role	NULL
in	NULL
B	NULL
cell-specific	NULL
gene	NULL
expression	NULL
and	NULL
disruption	NULL
of	NULL
this	NULL
interaction	NULL
due	NULL
to	NULL
chromosomal	NULL
translocations	NULL
or	NULL
other	NULL
chromosomal	NULL
abnormalities	NULL
could	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
B	NULL
cell	NULL
transformation	NULL
.	NULL

Further	NULL
experiments	NULL
using	NULL
other	NULL
B	NULL
cell-specific	NULL
gene	NULL
targets	NULL
will	NULL
be	NULL
extremely	NULL
interesting	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Scott	NULL
Hiebert	NULL
for	NULL
the	NULL
AML1	NULL
expression	NULL
construct	NULL
and	NULL
antiserum	NULL
against	NULL
AML1	NULL
;	NULL
Patty	NULL
Zwollo	NULL
and	NULL
Steve	NULL
Desiderio	NULL
for	NULL
BSAP	NULL
cDNA	NULL
and	NULL
bik	NULL
promoter	NULL
construct	NULL
;	NULL
Yan	NULL
Liu	NULL
for	NULL
the	NULL
excellent	NULL
technical	NULL
assistance	NULL
;	NULL
and	NULL
Marie-Térése	NULL
Little	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Miyoshi	NULL
,	NULL
H.	NULL
,	NULL
Shimizu	NULL
,	NULL
K.	NULL
,	NULL
Kozu	NULL
,	NULL
T.	NULL
,	NULL
Maseki	NULL
,	NULL
N.	NULL
,	NULL
Kaneko	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Ohki	NULL
,	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
10481-10484	NULL
2	NULL
.	NULL

Daga	NULL
,	NULL
A.	NULL
,	NULL
Tighe	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
and	NULL
Calabi	NULL
,	NULL
F.	NULL
(	NULL
1992	NULL
)	NULL
Nature	NULL
856	NULL
,	NULL
484	NULL
3	NULL
.	NULL

Wang	NULL
,	NULL
S.	NULL
,	NULL
Wang	NULL
,	NULL
Q.	NULL
,	NULL
Crute	NULL
,	NULL
B.	NULL
E.	NULL
,	NULL
Melnikova	NULL
,	NULL
I.	NULL
N.	NULL
,	NULL
Keller	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
and	NULL
Speck	NULL
,	NULL
N.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
3324-3339	NULL
4	NULL
.	NULL

Ogawa	NULL
,	NULL
E.	NULL
,	NULL
Maruyama	NULL
,	NULL
M.	NULL
,	NULL
Kagoshima	NULL
,	NULL
H.	NULL
,	NULL
Inuzuka	NULL
,	NULL
M.	NULL
,	NULL
Lu	NULL
,	NULL
J.	NULL
,	NULL
Satake	NULL
,	NULL
M.	NULL
,	NULL
Shigesada	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Ito	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
6859-6863	NULL
5	NULL
.	NULL

Levanon	NULL
,	NULL
D.	NULL
,	NULL
Negreanu	NULL
,	NULL
V.	NULL
,	NULL
Bernstein	NULL
,	NULL
Y.	NULL
,	NULL
Bar-Am	NULL
,	NULL
I.	NULL
,	NULL
Avivi	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Groner	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Genomics	NULL
28	NULL
,	NULL
425-432	NULL
6	NULL
.	NULL

Kagoshima	NULL
,	NULL
H.	NULL
,	NULL
Shigesada	NULL
,	NULL
K.	NULL
,	NULL
Satake	NULL
,	NULL
M.	NULL
,	NULL
Ito	NULL
,	NULL
Y.	NULL
,	NULL
Miyoshi	NULL
,	NULL
H.	NULL
,	NULL
Ohki	NULL
,	NULL
M.	NULL
,	NULL
Pepling	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Gergen	NULL
,	NULL
P.	NULL
(	NULL
1993	NULL
)	NULL
Trends	NULL
Genet	NULL
.	NULL

9	NULL
,	NULL
388-341	NULL
7	NULL
.	NULL

Zhang	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
Fujioka	NULL
,	NULL
K.	NULL
,	NULL
Hetherington	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Shapiro	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
Chen	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
Look	NULL
,	NULL
A.	NULL
T.	NULL
,	NULL
and	NULL
Tenen	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
8085-8095	NULL
8	NULL
.	NULL

Frank	NULL
,	NULL
R.	NULL
,	NULL
Zhang	NULL
,	NULL
J.	NULL
,	NULL
Uchida	NULL
,	NULL
H.	NULL
,	NULL
Meyers	NULL
,	NULL
S.	NULL
,	NULL
Hiebert	NULL
,	NULL
S.	NULL
W.	NULL
,	NULL
and	NULL
Nimer	NULL
,	NULL
S.	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
Oncogene	NULL
11	NULL
,	NULL
2667-2674	NULL
9	NULL
.	NULL

Hsiang	NULL
,	NULL
Y.	NULL
H.	NULL
,	NULL
Spencer	NULL
,	NULL
D.	NULL
,	NULL
Wang	NULL
,	NULL
S.	NULL
,	NULL
Speck	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
and	NULL
Raulet	NULL
,	NULL
D.	NULL
H.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

150	NULL
,	NULL
3905-3916	NULL
10	NULL
.	NULL

Cameron	NULL
,	NULL
S.	NULL
,	NULL
Taylor	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
TePas	NULL
,	NULL
E.	NULL
C.	NULL
,	NULL
Speck	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
and	NULL
Mathey-Prevot	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Blood	NULL
83	NULL
,	NULL
2851-2859	NULL
11	NULL
.	NULL

Suzow	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Friedman	NULL
,	NULL
A.	NULL
D.	NULL
(	NULL
1998	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
2141-2151	NULL
12	NULL
.	NULL

Nuchprayoon	NULL
,	NULL
I.	NULL
,	NULL
Meyers	NULL
,	NULL
S.	NULL
,	NULL
Scott	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Suzow	NULL
,	NULL
J.	NULL
,	NULL
Hiebert	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Friedman	NULL
,	NULL
A.	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
5558-5568	NULL
13	NULL
.	NULL

Westendorf	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Yamamoto	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Lenny	NULL
,	NULL
N.	NULL
,	NULL
Downing	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Selsted	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
and	NULL
Hiebert	NULL
,	NULL
S.	NULL
W.	NULL
(	NULL
1998	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
322-333	NULL
14	NULL
.	NULL

Giese	NULL
,	NULL
K.	NULL
,	NULL
Kingsley	NULL
,	NULL
C.	NULL
,	NULL
Kirshner	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
and	NULL
Grossched	NULL
]	NULL
,	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

9	NULL
,	NULL
995-1008	NULL
15	NULL
.	NULL

Hernandez-Munain	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Krangel	NULL
,	NULL
M.	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
473-483	NULL
16	NULL
.	NULL

Wang	NULL
,	NULL
Q.	NULL
,	NULL
Stacy	NULL
,	NULL
T.	NULL
,	NULL
Binder	NULL
,	NULL
M.	NULL
,	NULL
Marin-Padilla	NULL
,	NULL
M.	NULL
,	NULL
Sharpe	NULL
,	NULL
A.	NULL
H.	NULL
,	NULL
and	NULL
Speck	NULL
,	NULL
N.	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

98	NULL
,	NULL
3444-3449	NULL
17	NULL
.	NULL

Okuda	NULL
,	NULL
T.	NULL
,	NULL
van	NULL
Deursen	NULL
,	NULL
J.	NULL
,	NULL
Hiebert	NULL
,	NULL
S.	NULL
W.	NULL
,	NULL
Grosveld	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Downing	NULL
,	NULL
J.	NULL
R.	NULL
(	NULL
1996	NULL
)	NULL
Cell	NULL
84	NULL
,	NULL
821-330	NULL
18	NULL
.	NULL

Mitani	NULL
,	NULL
K.	NULL
,	NULL
Ogawa	NULL
,	NULL
S.	NULL
,	NULL
Tanaka	NULL
,	NULL
T.	NULL
,	NULL
Miyoshi	NULL
,	NULL
H.	NULL
,	NULL
Kurokawa	NULL
,	NULL
M.	NULL
,	NULL
Mano	NULL
,	NULL
H.	NULL
,	NULL
Yazaki	NULL
,	NULL
Y.	NULL
,	NULL
Ohki	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Hirai	NULL
,	NULL
H.	NULL
(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

13	NULL
,	NULL
504-510	NULL
19	NULL
.	NULL

Nucifora	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Rowley	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
Blood	NULL
86	NULL
,	NULL
1-14	NULL
20	NULL
.	NULL

Golub	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
Barker	NULL
,	NULL
G.	NULL
F.	NULL
,	NULL
Bohlander	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
Hiebert	NULL
,	NULL
S.	NULL
W.	NULL
,	NULL
Ward	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
Bray-Ward	NULL
,	NULL
P.	NULL
,	NULL
Morgan	NULL
,	NULL
E.	NULL
,	NULL
Raimondi	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Rowley	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Gilliland	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1995	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

92	NULL
,	NULL
4917-4921	NULL
21	NULL
.	NULL

Liu	NULL
,	NULL
P.	NULL
,	NULL
Tarle	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Hajra	NULL
,	NULL
A.	NULL
,	NULL
Claxton	NULL
,	NULL
D.	NULL
F.	NULL
,	NULL
Marlton	NULL
,	NULL
P.	NULL
,	NULL
Freedman	NULL
,	NULL
M.	NULL
,	NULL
Siciliano	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Collins	NULL
,	NULL
F.	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
261	NULL
,	NULL
1041-1044	NULL
22	NULL
.	NULL

Shurtleff	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Buijs	NULL
,	NULL
A.	NULL
,	NULL
Behm	NULL
,	NULL
F.	NULL
G.	NULL
,	NULL
Rubnitz	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Raimondi	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Hancock	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Chan	NULL
,	NULL
G.	NULL
C.	NULL
,	NULL
Pui	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
Grosveld	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Downing	NULL
,	NULL
J.	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
Leukemia	NULL
9	NULL
,	NULL
1985-1989	NULL
28	NULL
.	NULL

Hiebert	NULL
,	NULL
S.	NULL
W.	NULL
,	NULL
Sun	NULL
,	NULL
W.	NULL
,	NULL
Davis	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Golub	NULL
,	NULL
T.	NULL
,	NULL
Shurtleff	NULL
,	NULL
S.	NULL
,	NULL
Buijs	NULL
,	NULL
A.	NULL
,	NULL
Downing	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Grosveld	NULL
,	NULL
G.	NULL
,	NULL
Roussell	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Gilliland	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Lenny	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Meyers	NULL
,	NULL
S.	NULL
(	NULL
1996	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
,	NULL
1849-1355	NULL
AML	NULL
1	NULL
Regulates	NULL
the	NULL
blk	NULL
Promoter	NULL
24	NULL
.	NULL

Dymecki	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Niederhuber	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
and	NULL
Desiderio	NULL
,	NULL
S.	NULL
V.	NULL
(	NULL
1990	NULL
)	NULL
Science	NULL
247	NULL
,	NULL
332-336	NULL
25	NULL
.	NULL

Burkhardt	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
Brunswick	NULL
,	NULL
M.	NULL
,	NULL
Bolen	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
Mond	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
7410-7414	NULL
26	NULL
.	NULL

Lin	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Justement	NULL
,	NULL
L.	NULL
B	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

149	NULL
,	NULL
1548-1555	NULL
27	NULL
.	NULL

Mason	NULL
,	NULL
D.	NULL
Y.	NULL
,	NULL
Van	NULL
Noesel	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Cordell	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Comans-Bitter	NULL
,	NULL
W.	NULL
M.	NULL
,	NULL
Micklem	NULL
,	NULL
K.	NULL
,	NULL
Tse	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Van	NULL
Lier	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
Van	NULL
Dongen	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

22	NULL
,	NULL
2758-2756	NULL
28	NULL
.	NULL

Reth	NULL
,	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

10	NULL
,	NULL
97-121	NULL
29	NULL
.	NULL

Dymecki	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Zwollo	NULL
,	NULL
P.	NULL
,	NULL
Zeller	NULL
,	NULL
K.	NULL
,	NULL
Kubajda	NULL
,	NULL
F.	NULL
P.	NULL
,	NULL
and	NULL
Desiderio	NULL
,	NULL
S.	NULL
V.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
4815-4823	NULL
30	NULL
.	NULL

Yao	NULL
,	NULL
X.	NULL
R.	NULL
,	NULL
and	NULL
Scott	NULL
,	NULL
D.	NULL
W.	NULL
(	NULL
1998	NULL
)	NULL
Proc	NULL
.	NULL

Nafl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
7946-7950	NULL
31	NULL
.	NULL

Yao	NULL
,	NULL
X.	NULL
R.	NULL
,	NULL
and	NULL
Scott	NULL
,	NULL
D.	NULL
W.	NULL
(	NULL
19938	NULL
)	NULL
Immunol	NULL
.	NULL

Rev	NULL
.	NULL

182	NULL
,	NULL
163-186	NULL
32	NULL
.	NULL

Malek	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
Dordai	NULL
,	NULL
D.	NULL
I.	NULL
,	NULL
Reim	NULL
,	NULL
J.	NULL
,	NULL
Dintzis	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Desiderio	NULL
,	NULL
S.	NULL
(	NULL
1998	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

95	NULL
,	NULL
1351-7356	NULL
33	NULL
.	NULL

Zwollo	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Desiderio	NULL
,	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
15310-15317	NULL
34	NULL
.	NULL

Zwollo	NULL
,	NULL
P.	NULL
,	NULL
Rao	NULL
,	NULL
S.	NULL
,	NULL
Wallin	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Gackstetter	NULL
,	NULL
E.	NULL
R.	NULL
,	NULL
and	NULL
Koshland	NULL
,	NULL
M.	NULL
E.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

278	NULL
,	NULL
18647-18655	NULL
35	NULL
.	NULL

Barberis	NULL
,	NULL
A.	NULL
,	NULL
Widenhorn	NULL
,	NULL
K.	NULL
,	NULL
Vitelli	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Busslinger	NULL
,	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
849-859	NULL
36	NULL
.	NULL

Adams	NULL
,	NULL
B.	NULL
,	NULL
Dorfler	NULL
,	NULL
P.	NULL
,	NULL
Aguzzi	NULL
,	NULL
A.	NULL
,	NULL
Kozmik	NULL
,	NULL
Z.	NULL
,	NULL
Urbanek	NULL
,	NULL
P.	NULL
,	NULL
Maurer-Fogy	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Busslinger	NULL
,	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

6	NULL
,	NULL
1589-1607	NULL
37	NULL
.	NULL

Urbanek	NULL
,	NULL
P.	NULL
,	NULL
Wang	NULL
,	NULL
Z.	NULL
Q.	NULL
,	NULL
Fetka	NULL
,	NULL
L.	NULL
,	NULL
Wagner	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
and	NULL
Busslinger	NULL
,	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
79	NULL
,	NULL
901-912	NULL
38	NULL
.	NULL

Kozmik	NULL
,	NULL
Z.	NULL
,	NULL
Wang	NULL
,	NULL
S.	NULL
,	NULL
Dorfler	NULL
,	NULL
P.	NULL
,	NULL
Adams	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Busslinger	NULL
,	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
2662-2672	NULL
39	NULL
.	NULL

Singh	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Birshtein	NULL
,	NULL
B.	NULL
K.	NULL
(	NULL
1998	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
8611-8622	NULL
40	NULL
.	NULL

Liao	NULL
,	NULL
F.	NULL
,	NULL
Birshtein	NULL
,	NULL
B.	NULL
K.	NULL
,	NULL
Busslinger	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Rothman	NULL
,	NULL
P.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

152	NULL
,	NULL
2904-2911	NULL
41	NULL
.	NULL

Neurath	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Strober	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Wakatsuki	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

153	NULL
,	NULL
730-742	NULL
42	NULL
.	NULL

Neurath	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Stuber	NULL
,	NULL
E.	NULL
R.	NULL
,	NULL
and	NULL
Strober	NULL
,	NULL
W.	NULL
(	NULL
1995	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
16	NULL
,	NULL
564-569	NULL
43	NULL
.	NULL

Rinkenberger	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Wallin	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Johnson	NULL
,	NULL
K.	NULL
W.	NULL
,	NULL
and	NULL
Koshland	NULL
,	NULL
M.	NULL
E.	NULL
(	NULL
1996	NULL
)	NULL
Immunity	NULL
.	NULL

5	NULL
,	NULL
377-386	NULL
44	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
Muller	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
and	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
6419	NULL
45	NULL
.	NULL

Zhang	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
Hetherington	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Chen	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
and	NULL
Tenen	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
873-381	NULL
46	NULL
.	NULL

Meyers	NULL
,	NULL
S.	NULL
,	NULL
Downing	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
and	NULL
Hiebert	NULL
,	NULL
S.	NULL
W.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
6336-6345	NULL
47	NULL
.	NULL

Octtgen	NULL
,	NULL
P.	NULL
,	NULL
Akbarali	NULL
,	NULL
Y.	NULL
,	NULL
Boltax	NULL
,	NULL
J.	NULL
,	NULL
Best	NULL
,	NULL
J.	NULL
,	NULL
Kunsch	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Libermann	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
,	NULL
5091-5106	NULL
48	NULL
.	NULL

Zhang	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
Hetherington	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Meyers	NULL
,	NULL
S.	NULL
,	NULL
Rhoades	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
Larson	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Chen	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
Hiebert	NULL
,	NULL
S.	NULL
W.	NULL
,	NULL
and	NULL
Tenen	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1996	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
,	NULL
1231-1240	NULL
49	NULL
.	NULL

Petrovick	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
Hiebert	NULL
,	NULL
S.	NULL
W.	NULL
,	NULL
Friedman	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Hetherington	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Tenen	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
and	NULL
Zhang	NULL
,	NULL
D.	NULL
E.	NULL
(	NULL
1998	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
8915-3925	NULL
50	NULL
.	NULL

Wang	NULL
,	NULL
S.	NULL
W.	NULL
,	NULL
and	NULL
Speck	NULL
,	NULL
N.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
89-102	NULL
51	NULL
.	NULL

Czerny	NULL
,	NULL
T.	NULL
,	NULL
Schaffner	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Busslinger	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

7	NULL
,	NULL
2048-2061	NULL
52	NULL
.	NULL

Rowley	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Semin	NULL
.	NULL

Hematol	NULL
.	NULL

27	NULL
,	NULL
122-136	NULL
53	NULL
.	NULL

Erickson	NULL
,	NULL
P.	NULL
,	NULL
Gao	NULL
,	NULL
J.	NULL
,	NULL
Chang	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
Look	NULL
,	NULL
T.	NULL
,	NULL
Whisenant	NULL
,	NULL
E.	NULL
,	NULL
Raimondi	NULL
,	NULL
S.	NULL
,	NULL
Lasher	NULL
,	NULL
R.	NULL
,	NULL
Trujillo	NULL
,	NULL
J.	NULL
,	NULL
Rowley	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Drabkin	NULL
,	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
Blood	NULL
80	NULL
,	NULL
1825-1831	NULL
54	NULL
.	NULL

Nisson	NULL
,	NULL
P.	NULL
E.	NULL
,	NULL
Watkins	NULL
,	NULL
P.	NULL
C.	NULL
,	NULL
and	NULL
Sacchi	NULL
,	NULL
N.	NULL
(	NULL
1992	NULL
)	NULL
Cancer	NULL
Genet	NULL
.	NULL

Cytogenet	NULL
.	NULL

63	NULL
,	NULL
81-88	NULL
55	NULL
.	NULL

Tenen	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Hromas	NULL
,	NULL
R.	NULL
,	NULL
Licht	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Zhang	NULL
,	NULL
D.	NULL
E.	NULL
(	NULL
1997	NULL
)	NULL
Blood	NULL
90	NULL
,	NULL
489-519	NULL
56	NULL
.	NULL

Shivdasani	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1996	NULL
)	NULL
Blood	NULL
87	NULL
,	NULL
4025-4039	NULL
57	NULL
.	NULL

Erman	NULL
,	NULL
B.	NULL
,	NULL
Cortes	NULL
,	NULL
M.	NULL
,	NULL
Nikolajezyk	NULL
,	NULL
B.	NULL
S.	NULL
,	NULL
Speck	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
and	NULL
Sen	NULL
,	NULL
R.	NULL
(	NULL
1998	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
1822-1330	NULL
58	NULL
.	NULL

Meyers	NULL
,	NULL
S.	NULL
,	NULL
Lenny	NULL
,	NULL
N.	NULL
,	NULL
Sun	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Hiebert	NULL
,	NULL
S.	NULL
W.	NULL
(	NULL
1996	NULL
)	NULL
Oncogene	NULL
18	NULL
,	NULL
303-312	NULL
59	NULL
.	NULL

Fitzsimmons	NULL
,	NULL
D.	NULL
,	NULL
Hodsdon	NULL
,	NULL
W.	NULL
,	NULL
Wheat	NULL
,	NULL
W.	NULL
,	NULL
Maira	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Wasylyk	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Hagman	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

10	NULL
,	NULL
2198-2211	NULL
60	NULL
.	NULL

Wotton	NULL
,	NULL
D.	NULL
,	NULL
Ghysdael	NULL
,	NULL
J.	NULL
,	NULL
Wang	NULL
,	NULL
S.	NULL
,	NULL
Speck	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
and	NULL
Owen	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
840-850	NULL
61	NULL
.	NULL

Britos-Bray	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Friedman	NULL
,	NULL
A.	NULL
D.	NULL
(	NULL
1997	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17	NULL
,	NULL
5127-5135	NULL
62	NULL
.	NULL

Nutt	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Urbanek	NULL
,	NULL
P.	NULL
,	NULL
Rolink	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Busslinger	NULL
,	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

11	NULL
,	NULL
476-491	NULL
63	NULL
.	NULL

Busslinger	NULL
,	NULL
M.	NULL
,	NULL
Klix	NULL
,	NULL
N.	NULL
,	NULL
Pfeffer	NULL
,	NULL
P.	NULL
,	NULL
Graninger	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
and	NULL
Kozmik	NULL
,	NULL
Z	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

98	NULL
,	NULL
6129-6184	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
AML1	NULL
(	NULL
CBFo2	NULL
)	NULL
Cooperates	NULL
with	NULL
B	NULL
Cell-specific	NULL
Activating	NULL
Protein	NULL
(	NULL
BSAP/PAX5	NULL
)	NULL
in	NULL
Activation	NULL
of	NULL
the	NULL
B	NULL
Cell-specific	NULL
BLK	NULL
Gene	NULL
Promoter	NULL
Towia	NULL
A.	NULL
Libermann	NULL
,	NULL
Zheng	NULL
Pan	NULL
,	NULL
Yasmin	NULL
Akbarali	NULL
,	NULL
Christopher	NULL
J.	NULL
Hetherington	NULL
,	NULL
Jay	NULL
Boltax	NULL
,	NULL
Donald	NULL
A.	NULL
Yergeau	NULL
and	NULL
Dong-Er	NULL
Zhang	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1999	NULL
,	NULL
274:24671-24676.	NULL
doi	NULL
:	NULL
10.1074/jb0.274.35.24671	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/274/35/24671	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
63	NULL
references	NULL
,	NULL
45	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
.	NULL

full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL

